See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Research Area · Atherosclerosis

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
19500 11-dehydro Thromboxane B2 67910-12-7 ≥98% 53.282243093923 11-dehydro-thromboxane-b2 11-keto TXB2; 11-dehydro TXB2 metabolites thromboxanes plasma 11-dehydro-TXB2 11-keto-TXB2 atherosclerosis 53.282243093923
319500 11-dehydro Thromboxane B2-d4 - ≥99% deuterated product 25.379875690608 11-dehydro-thromboxane-b2-d4 11-keto TXB2-d4 GC/MS deuterium isotopes 11-dh-TXB2-d4 internal standards thromboxanes 11-dehydro-TXB2-d4 deuterated GC-MS LC/MS LC-MS mass spectrometry atherosclerosis 25.379875690608
519510 11-dehydro Thromboxane B2 EIA Kit - Monoclonal New - 2012-02-08 215.601734960098 11-dehydro-thromboxane-b2-eia-kit-monoclonal 11-dehydro TXB2 ELISA Kit 11-dehydro-TXB2 enzymes immunoassays EIAs ELISAs kits assays measures measurements competitive quantification thromboxanes A2 TXA2 arachidonic acids platelets aggregation vascular bronchial smooth muscles hydrolyzed plasma urine ex vivo activation intra-renal production metabolites kidneys metabolized dehydrogenases enzymes cytosolic aldehydes peroxisomes peroxisomal b-oxidations beta-oxidations .beta.-oxidations β-oxidations infusions study studies circulating half-life t1/2 2,3-dinor 11-dehydro-2,3-dinor gas chromatography mass spectrometry GC/MS dosing doses aspirin acetylsalicylic acid NSAIDS nonsteroidal anti-inflammatory drugs smokers levels non-enzymatically 215.601734960098
10007239 11-dehydro Thromboxane B2 Lipid Maps MS Standard 67910-12-7 ≥98% 2009-01-16 14.814704025256 11-dehydro-thromboxane-b2-lipid-maps-ms-standard 11-dehydro TXB2; 11-keto TXB2 metabolites thromboxanes plasma 11-dehydro-TXB2 11-keto-TXB2 atherosclerosis MS mass spectrometry standards 14.814704025256
10006831 11-dehydro Thromboxane B2 Quant-PAK - 2005-08-08 18.654438305709 11-dehydro-thromboxane-b2-quant-pak Quant-PAKs metabolites thromboxanes plasma deuterium isotopes 11-dh-TXB2-d4 internal standards 11-dehydro-TXB2-d4 deuterated GC/MS GC-MS LC/MS LC-MS mass spectrometry atherosclerosis packs 18.654438305709
160304 12-Lipoxygenase (murine leukocyte) Polyclonal Antiserum - 52.739530386740 12-lipoxygenase-murine-leukocyte-polyclonal-antiserum 12-LO; 12-LOX 12-LOs leukocyte 12-lipoxygenases western blots blotting WB antisera antibodies antiserum atherosclerosis immunoblotting 52.739530386740
34590 12(S)-HHTrE 54397-84-1 ≥97% 52.589631675875 12-s-hhtre 12(S)-HHT platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis 12(s)-hhtre 12(s)-hhtre 52.589631675875
10007250 12(S)-HHTrE Lipid Maps MS Standard 54397-84-1 ≥97% 2009-02-26 35.295558011050 12-s-hhtre-lipid-maps-ms-standard 12-HHT platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis MS mass spectrometry standards 35.295558011050
10010425 13,14-dihydro-15-keto Prostaglandin D1 Exclusive - >98% ✓ 2008-05-09 0.494944751381 13-14-dihydro-15-keto-prostaglandin-d1 13,14-dihydro-15-keto PGD1 PGD1 prostaglandins metabolites DGLA dihomo-.gamma.-linolenic acid dihomo-gamma-linolenic dihomo-y-linolenic PGDs pathways 0.494944751381
38601 (±)13-HODE cholesteryl ester 167354-91-8 ≥98% 6.674769797421 -13-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids (+/-)13-HODEs esters racemic 6.674769797421
10704 (±)13-HpODE 23017-93-8 ≥98% 2011-02-24 41.493991712707 -13-hpode hydroperoxides lipids linoleic acids reactive oxygen species oxidative stress injury 41.493991712707
38606 13(R)-HODE cholesteryl ester - ≥98% 1.150773480663 13-r-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids 13-HODEs 13R-HODEs esters 1.150773480663
38611 13(S)-HODE cholesteryl ester - ≥98% 16.147071823204 13-s-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids 13-HODEs 13S-HODEs esters 13(S)HODEs 13(S)-HODEs 16.147071823204
39620 13(S)-HOTrE 87984-82-5 ≥98% 4.362099447513 13-s-hotre linolenic acids hydroxy metabolites 13S-HOTrEs 13-HOTrEs fatty 13(S)-HOTrEs 13(S)HOTrEs 4.362099447513
48610 13(S)-HpODE 33964-75-9 >98% 84.117219152854 13-s-hpode linoleic hydroperoxides 13S-HpODEs 13-HpODEs hydroperoxy fatty acids 13(S)-HpODEs 84.117219152854
18570 15-deoxy-Δ12,14-Prostaglandin J2 87893-55-8 ≥95% 157.498670963781 15-deoxy-12-14-prostaglandin-j2 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands 15dpgj2 atherosclerosis 157.498670963781
318570 15-deoxy-Δ12,14-Prostaglandin J2-d4 - ≥99% deuterated product 45.031193370165 15-deoxy-12-14-prostaglandin-j2-d4 15-deoxy-Δ12,14-PGJ2-d4 GC/MS deuterium isotopes 15-deoxy-DELTA12,14-PGJ2-d4 15-deoxy-.DELTA.12,14-PGJ2-d4 15-deoxy-D12,14-PGJ2-d4 internal standards prostaglandins deuterated mass spectrometry GC-MS LC-MS LC/MS atherosclerosis 45.031193370165
10007235 15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard 87893-55-8 ≥97% 2009-01-16 51.545994475138 15-deoxy-12-14-prostaglandin-j2-lipid-maps-ms-standard 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands atherosclerosis MS mass spectrometry standards 51.545994475138
160704 15-Lipoxygenase-1 (rabbit) Polyclonal Antiserum - 23.622891344382 15-lipoxygenase-1-rabbit-polyclonal-antiserum 15-LO-1; 15-LOX-1 15-LOs antibody Western blots 15-lipoxygenases blotting antisera antiserum antibodies atherosclerosis WB immunoblotting 23.622891344382
10010468 15-Lipoxygenase Inhibitor 1 Exclusive 928853-86-5 ≥98% ✓ 2008-10-23 39.314433220636 15-lipoxygenase-inhibitor-1 15-LO Inhibitor 1 15-LOs inhibitors inhibits inhibition oxidation inflammation thrombosis cancers lipoxygenases pyrimidobenzothiazine antioxidants 39.314433220636
13076 16(R)-Iloprost - ≥98% 2008-10-10 20.081736385161 16-r-iloprost prostacyclin platelet aggregation IP receptors EP vasodilation pulmonary hypertension stereoisomers inhibits inhibitors inhibition iloprosts PGI2 20.081736385161
13077 16(S)-Iloprost 74843-14-4 ≥98% 2008-10-10 20.081736385161 16-s-iloprost prostacyclin platelet aggregation IP receptors EP vasodilation pulmonary hypertension stereoisomers iloprosts inhibits inhibitors inhibition PGI2 20.081736385161
10010164 1-Octadecyl Lysophosphatidic Acid Exclusive 52977-29-4 ≥95% ✓ 2008-06-04 8.188434622467 1-octadecyl-lysophosphatidic-acid 1-Octadecyl LPA LPAs lysophosphatidic cells proliferation smooth muscles platelet aggregation neurite proteins sn-1 aggregating 8.188434622467
10010291 1-Octadecyl Lysophosphatidic Acid (sodium salt) Exclusive - >95% ✓ 2008-03-17 16.071694290976 1-octadecyl-lysophosphatidic-acid-sodium-salt 1-Octadecyl LPA (sodium salt) LPA G-proteins receptors cell proliferations smooth muscle contractions platelet aggregations cell motility EDG receptors 16.071694290976
10009431 1-Stearoyl-2-Arachidonoyl PC-d8 Exclusive - 99% deuterated product ✓ 2009-07-24 14.387154696133 1-stearoyl-2-arachidonoyl-pc-d8 SAPC-d8; 1-Stearoyl-2-Arachidonoyl Phosphatidylcholine-d8 SAPC LDL oxidation inflammation cardiovascular disease phospholipids LC/MS GC/MS deuterated deuteriums mass spectrometry MS LC-MS GC-MS standards 14.387154696133
515121 2,3-dinor-6-keto Prostaglandin F1α EIA Kit - 2006-05-23 157.716198895028 2-3-dinor-6-keto-prostaglandin-f1-eia-kit 2,3-dinor-6-keto PGF1α ELISA Kit solid plates enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction inhibits cyclooxygenases atherosclerosis stroke COX-2 measures kits PGF1a assays 157.716198895028
519051 2,3-dinor Thromboxane B2 EIA Kit - 104.155642914482 2-3-dinor-thromboxane-b2-eia-kit 2,3-dinor Thromboxane B2 ELISA Kit solid plates 2,3-dinor-TXB2 metabolites thromboxanes measures kits eias enzyme atherosclerosis immunoassays ELISAs assays 104.155642914482
10397 3-amino Benzamide New 3544-24-9 ≥98% 2011-10-07 2.289024419063 3-amino-benzamide 3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated 2.289024419063
13221 3-hexanoyl-NBD Cholesterol - ≥98% 2009-06-05 9.098342541437 3-hexanoyl-nbd-cholesterol 3-C6-NBD Cholesterol fluorescent cholesterol NBD fluorophore membrane lipids flourescently-tagged probes 9.098342541437
9000368 3-hydroxy-3-methylglutaryl-Coenzyme A-d3 (ammonium salt) Exclusive - ≥99% deuterated product ✓ 2009-04-20 3.930939226519 3-hydroxy-3-methylglutaryl-coenzyme-a-d3-ammonium-salt HMG-CoA-d3 HMG-CoA mevalonic acid mevalonate cholesterol steroids sterols deuterateds deuterium standards GC MS LC mass spetrometry 3.930939226519
90500 3-Thiatetradecanoic Acid 116296-31-2 >98% 2004-02-06 0.860817679558 3-thiatetradecanoic-acid 3-TDA thioether myristic analogs PPAR ligands peroxisome proliferator-activated receptors oleic acids D9-desaturases .DELTA.9-desaturases DELTA9-desaturases atherosclerosis 0.860817679558
90312 4,5-dehydro Docosahexaenoic Acid - ≥98% 20.457495395948 4-5-dehydro-docosahexaenoic-acid 4,5-dehydro Cervonic Acid; 4,5-dehydro DHA w-3 fatty acids omega-3 .omega.-3 n-3 analogs acetylene 5-LO 5-lipoxygenases inhibits inhibitors 20.457495395948
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% ✓ 2010-06-16 121.635972989564 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 121.635972989564
60402 5-Lipoxygenase (human recombinant) - cell ly100,000 x g supernatant 55.620839998900 5-lipoxygenase-human-recombinant 5-LO; 5-LOX 5-LOs enzymes 5-lipoxygenases atherosclerosis 55.620839998900
10009638 5-Lipoxygenase (human recombinant) Western Ready Control - 78 kDa (His-tagged), 74 kDa (native) 2007-07-27 13.734042357274 5-lipoxygenase-human-recombinant-western-ready-control 5-LOX; 5-LO western blot WB 5(S)-HETE arachidonic acids leukotrienes rat basophilic leukemia alveolar eosinophils mast epithelial lungs blood 13.734042357274
10007820 5-Lipoxygenase (Phospho-Ser523) Polyclonal Antibody - 2006-09-13 7.691938724259 5-lipoxygenase-phospho-ser523-polyclonal-antibody 5-LO (Phospho-Ser523) Polyclonal Antibody wb western blotting blots antibodies regulation leukotrienes asthma fibrosis atherosclerosis inflammation regulating phospho-specific immunoblotting 7.691938724259
160402 5-Lipoxygenase Polyclonal Antibody - 32.770187845303 5-lipoxygenase-polyclonal-antibody 5-LO; 5-LOX 5-LOs LTA4 asthma 5-lipoxygenases leukotrienes antisera western blots blotting WB antibodies antiserum icc immunocytochemistry atherosclerosis immunoblotting ihc immunohistochemistry 32.770187845303
10007601 5α-hydroxy-6-keto Cholesterol 13027-33-3 ≥98% 2005-11-11 123.095877560131 5-hydroxy-6-keto-cholesterol 6-Oxo-3,5-diol; Cholestane-6-oxo-3β,5α-diol atherosclerosis cholesterols ozonolysis cytotoxicity metabolites ozone-oxidized lipids surfactants lungs epithelials lining fluids exposures cells bronchalveoalar lavaged homogenates inhibits inhibitors synthesis bronchial cytotoxicity toxic oxysterols hydroxycholesterol 123.095877560131
15210 6-keto Prostaglandin F1α 58962-34-8 >99% 56.309966850828 6-keto-prostaglandin-f1 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis 56.309966850828
315210 6-keto Prostaglandin F1α-d4 - ≥99% deuterated product 16.896099447513 6-keto-prostaglandin-f1-d4 6-keto PGF1α-d4 GC/MS deuterium isotopes 6-keto-PGF1a-d4 6-keto-PGF1alpha-d4 6-keto-PGF1.alpha.-d4 internal standards prostaglandins PGFα deuterated LC/MS GC-MS LC-MS mass spectrometry d4 atherosclerosis 16.896099447513
515211 6-keto Prostaglandin F1α EIA Kit - 520.380412318396 6-keto-prostaglandin-f1-eia-kit 6-keto Prostaglandin F1α ELISA Kit solid plates 6-keto-PGF1alpha 6-keto-PGF1.alpha. prostaglandins measures kits eias atherosclerosis enzyme immunoassays ELISAs 6-keto Prostaglandin F1.alpha. EIA Kit assays 520.380412318396
10007219 6-keto Prostaglandin F1α Lipid Maps MS Standard 58962-34-8 >99% 2008-12-17 37.604464088398 6-keto-prostaglandin-f1-lipid-maps-ms-standard 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards 37.604464088398
10312 8,12-iso-iPF2α-VI-1,5-lactone Exclusive - ≥98% ✓ 2009-08-07 6.250128913443 8-12-iso-ipf2-vi-1-5-lactone lactone IPF2α -I iPF2α-VI F2-iP urine lipid peroxidation plasma biomarker oxidative stress 214894-81-2 214894-83-4 6.250128913443
10007850 9,11-methane-epoxy Prostaglandin F1α 72517-81-8 >96% 2006-05-10 182.245248618784 9-11-methane-epoxy-prostaglandin-f1 9,11-Epoxymethano PGH1 prostaglandins PGs endoperoxides TXs thromboxanes prostacyclins PGH1 platelets smooth muscles analogs aggregation aorta aortic tracheas histamines coronary perfusion atherosclerosis 182.245248618784
38401 (±)9-HODE cholesteryl ester 33783-76-5 ≥98% 16.629097605893 -9-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids esters (+/-)9-HODEs (+/-)-HODEs (+/-)HODEs racemic 16.629097605893
38406 9(R)-HODE cholesteryl ester - ≥98% 1.087108655617 9-r-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids esters 9R-HODEs 9-HODEs 9(R)-HODEs 9(R)HODEs 1.087108655617
38410 9(S)-HODE 73543-67-6 ≥98% 19.062651933701 9-s-hode linoleic acids hydroxy oxidized 9S-HODEs 9-HODEs fatty 9(S)-HODEs 9(S)HODEs 19.062651933701
38411 9(S)-HODE cholesteryl ester - ≥98% 2.153314917127 9-s-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids hydroxy fatty acids 9-HODEs esters 9S-HODEs 9(S)-HODEs 9(S)HODEs 2.153314917127
338410 9(S)-HODE-d4 - ≥99% deuterated product 17.761325966851 9-s-hode-d4 GC/MS deuterium isotopes 9-HODE-d4 standards 9S-HODE-d4 deuterated GC-MS LC/MS LC-MS 9-HODEs 9(S)-HODEs 9S-HODEs 9(S)HODES hydroxy fatty acids 9(S)HODE-d4 mass spectrometry 17.761325966851
100028 ACAT-1 Polyclonal Antibody - 2004-04-28 42.766595303867 acat-1-polyclonal-antibody Sterol O-Acyltransferase 1; Acyl-coenzyme A: Cholesterol Acyltransferase-1; Cholesterol Acyltransferase 1; SOAT1 Acyl-coenzyme A: cholesterol acyltransferase-1 esters ACAT1 atherosclerosis antibodies antisera antiserum western blots blotting wb icc immunocytochemistry ihc immunohistochemistry immunoblotting 42.766595303867
100027 ACAT-2 Polyclonal Antibody - 2004-04-26 39.467755524862 acat-2-polyclonal-antibody Sterol O-Acyltransferase 2; Acyl-coenzyme A: Cholesterol Acyltransferase-2 Acyl-coenzyme A: cholesterol acyltransferase-2 esters ACAT2 atherosclerosis antibodies antisera antiserum western blots blotting wb icc immunocytochemistry ihc immunohistochemistry immunoblotting 39.467755524862
10007686 Acetyl Podocarpic Acid Anhydride Exclusive 344327-48-6 >98% ✓ 2007-07-11 281.868121546961 acetyl-podocarpic-acid-anhydride APD receptors ABC1 ABCA1 oxysterol cholesterol LXRalpha LXR.alpha. LXRbeta LXR.beta. 7.alpha.-hydroxylase RXR retinoid agonists nuclear receptors atherosclerosis acetyls podocaysics acids anhydrides livers hormones atherosclerosis 281.868121546961
589451 AcSDKP EIA Kit - 102.998563535911 acsdkp-eia-kit N-Acetyl Ser-Asp-Lys-Pro EIA Kit; AcSDKP ELISA Kit N-Acetyl-Seryl-Aspartyl-Lysyl-Proline serine aspartamine lysine measures kits eias enzyme immunoassays ELISAs growth regulatory hormones plasma urine spi-bio spibio A05881 atherosclerosis hypertension endocrinology assays 102.998563535911
10092 Adenosine Receptor A2A Blocking Peptide - 2009-04-03 152.562306629834 adenosine-receptor-a2a-blocking-peptide A2AR blocking peptides Western blots immunoblotting ARA2A 152.562306629834
10006908 Adipogenesis Assay Kit - 2006-08-18 82.688214714396 adipogenesis-assay-kit obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines endocrinology cell-based assays cell based assay cba 82.688214714396
10009381 Adipolysis Assay Kit - 2007-07-30 59.419943270406 adipolysis-assay-kit obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines lipolysis 3T3L1 kits assays FFA adipocytes endocrinology cell-based assay cell based assay cba 59.419943270406
10008492 Adipose Triglyceride Lipase Blocking Peptide - 2006-06-27 8.294806629834 adipose-triglyceride-lipase-blocking-peptide ATGL; TG-hydrolase inducible PLA2-ζ; Desnutrin antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis 8.294806629834
10006409 Adipose Triglyceride Lipase Polyclonal Antibody - 2005-11-23 16.582722967639 adipose-triglyceride-lipase-polyclonal-antibody Phospholipase A2ζ; Desnutrin; ATGL antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis immunoblotting 16.582722967639
19023 AH 23848 (calcium salt, hydrate) - ≥90% 2009-02-26 56.043558011050 ah-23848-calcium-salt-hydrate AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 56.043558011050
10010241 AICAR 2627-69-2 >98% 2008-02-25 141.414828729282 aicar NSC 105823; Acadesine; AICA Riboside AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide 141.414828729282
589301 Angiotensin II EIA Kit - 155.747090176983 angiotensin-ii-eia-kit Angiotensin II ELISA Kit hypertension angiotensin measures kits eias enzyme immunoassays ELISAs spi-bio spibio A05880 atherosclerosis endocrinology assays 155.747090176983
580170 ANGPTL3 (human) EIA Kit New - 2012-01-10 110.448067613786 angptl3-human-eia-kit Angiopoietin-like protein 3 kits assays measures measurements angiopoietin-like proteins ANGPTLs angiopoietin-related growth factors AGF ligands regulated regulation angiogenesis glucose lipids energy metabolisms ANGPTL1 ANGPTL2 ANGPTL4 ANGPTL5 ANGPTL6 ANGPTL7 N-terminal N-terminus coiled-coil domains C-terminal C-terminus fibrinogen-like angiopoietins receptors Tie2 proteins Tie1 livers pro-angiogenic integrins αvβ3 endothelial cells migration adhesion inhibits inhibitors inhibition catalytic lipoproteins lipases catalyzes hydrolysis triglycerides HDL high density phospholipids hypolipidemic obese ob KK/Snk mice mouse expression hyperlipidemia atherosclerosis plasma human cholesterols immunometrics sandwich serums cultures supernatants 110.448067613786
13079 ApoAI Blocking Peptide - 2008-09-30 18.108287292818 apoai-blocking-peptide Apolipoprotein A-I; Apolipoprotein AI antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots 18.108287292818
13042 ApoAI Monoclonal Antibody (Clone CC3821C4) Exclusive - ✓ 2008-10-15 23.606390423572 apoai-monoclonal-antibody-clone-cc3821c4 Apolipoprotein AI antibodies HDL high-density lipoproteins WB western blots polypeptide immunoblotting blotting A-I A-1 apopipoproteins 23.606390423572
10008463 ApoAI Polyclonal Antibody - 2006-03-30 34.819992107340 apoai-polyclonal-antibody Apolipoprotein A-I; Apolipoprotein AI atherosclerosis proteins diseases antibodies antisera antiserum WB western blotting ICC immunocytochemistry ApoA1 ApoA-1 Apo A-1 Apo A1 Apo AI Apo-A1 Apo-AI blots immunoblotting 34.819992107340
10009751 ApoAI Western Ready Control - 2007-07-11 14.129309392265 apoai-western-ready-control Apolipoprotein AI western blots WB high-density lipoproteins HDL liver phospholipids excretion steroidogenesis blotting ApoA-1 atherosclerosis ApoA1 ApoA-I 14.129309392265
70260 Aspirin 50-78-2 >99% 10.936541659691 aspirin Acetylsalicylic Acid atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits 10.936541659691
10010153 Aspirin™ Effect-Detection Kit - 2007-06-08 112.700382647841 aspirin-effect-detection-kit use:human 11-dehydro-TXB2 enzyme immunoassays ELISAs kits measures metabolites atherosclerosis thromboxanes eias analysistools:eia atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits atherosclerosis assays 112.700382647841
10005292 Atherosclerosis Product Pack - 2004-09-09 4.115082872928 atherosclerosis-product-pack Acyl-coenzyme A: cholesterol acyltransferase-1 esters ACAT1 atherosclerosis inhibitors inhibits inhibition CETP WB blots blotting IHC immunohistochemistry JTT-705 89450 packs 4.115082872928
589401 Atriopeptin (rat) EIA Kit - 37.020331491713 atriopeptin-rat-eia-kit Atriopeptin (rat) ELISA Kit naturiuretic auriculin measures kits eias enzyme immunoassays ELISAs atherosclerosis pi-bio spibio A05103 hypertension endocrinology assays 37.020331491713
60924 Azelaoyl PAF - >98% 63.528618784530 azelaoyl-paf PPAR gamma oxidized LDL lipids agonist atherosclerosis nuclear receptors 63.528618784530
10010266 BAY-11-7082 19542-67-7 ≥98% 2008-07-25 29.500721085946 bay-11-7082 inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 29.500721085946
18230 Beraprost (sodium salt) 88475-69-8 >98% 90.588057793279 beraprost-sodium-salt TRK 100; Procyclin; ML 1129 prostaglandins inhibitors inhibits PGI2 prostacyclin platelets aggregation pulmonary atherosclerosis hypertension analogs salts ML-1129 ML1129 TRK-100 TRK100 Na+ 90.588057793279
10006427 Berberine 633-65-8 >95% 2005-05-25 7.901885359115 berberine Umbellatine; BBR natural alkoloid hypocholesterolemic activity berberidaceaen medicine antiprotozoal antidiahreal agents reduces total cholesterol LDLR low-density lipoproteins triglycerides high fat diet LDL-receptors proteins mRNA levels hepatocytes serum atherosclerosis 7.901885359115
10009145 Bezafibrate 41859-67-0 >98% 2007-08-02 4.529834254143 bezafibrate Difaterol; Bezatrol; Bezalip; BM 15075; Benzofibrate PPAR PPAR.alpha. PPAR.delta. PPAR.gamma. agonist Pan-PPAR cholesterol atherosclerosis metabolic syndromes LDL HDL proliferator-activated receptors diabetes low-density high-density lipoproteins atherosclerosis cardiovascular PPARa PPARd PPARg endocrinology fibrate 4.529834254143
10010517 BIBB 515 156635-05-1 ≥98% 2008-06-16 1.130552486188 bibb-515 inhibitor inhibits inhibition BIBB515 OSC LDL 2,3-oxidosqualene cyclase cholesterol BIBB-515 1.130552486188
120114 BLT1 Receptor Polyclonal Antibody - 6.257085635358 blt1-receptor-polyclonal-antibody Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc atherosclerosis immunoblotting FC 6.257085635358
100019 BLT1 Receptor Polyclonal Antiserum - 2.450441988950 blt1-receptor-polyclonal-antiserum Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 C-terminus C-terminal intracellular plasma membranes whole cells LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc chronic pancreatitis pancreatic cancers pancreas atherosclerosis immunoblotting FC 2.450441988950
120124 BLT2 Receptor Polyclonal Antibody - 102.211368465787 blt2-receptor-polyclonal-antibody Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2 LTB4R2 LTB4-R2 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera western blots blotting WB atherosclerosis immunoblotting 102.211368465787
10155 BM 567 284464-77-3 >98% 2005-03-31 51.973006445672 bm-567 platelets thromboxanes TXA2 atherosclerosis synthases inhibits inhibition inhibitors antagonists BM567 BM-567 thrombogenic vasocontrictors TP receptors eicosanoids strokes myocardial infarctions GPCR vascular smooth muscles protein-coupled license:liege 51.973006445672
60928 Butanoyl PAF - >98% 14.343259668508 butanoyl-paf ox-LDL signaling molecules oxLDL oxidized low-density lipoproteins PMNL polymorphonuclear leukocytes platelet-activating factors atherosclerosis 14.343259668508
60929 Butenoyl PAF - >98% 10.023591160220 butenoyl-paf ox-LDL signaling molecules oxLDL oxidized low-density lipoproteins PMNL polymorphonuclear leukocytes platelet-activating factors atherosclerosis 10.023591160220
13285 Cannabidiol dimethyl ether 1242-67-7 ≥98% 2009-05-19 12.557320441989 cannabidiol-dimethyl-ether Cannabidiol-2',6'-dimethyl ether; CBDD 15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic 12.557320441989
18210 Carbaprostacyclin 69552-46-1 >99% 113.252704139898 carbaprostacyclin Carbacyclin; cPGI analogs vasodilation PPARs peroxisome proliferator-activated receptors PGI2 prostaglandins atherosclerosis cPGI Carbacyclin 113.252704139898
9000183 Carbaprostacyclin methyl ester Exclusive 69552-55-2 ≥98% ✓ 2010-11-29 27.163038674033 carbaprostacyclin-methyl-ester prostacyclins prostaglandins I2 PGI2 IPs PPARδ stable analog activate activation 27.163038674033
19010 Carbocyclic Thromboxane A2 74034-56-3 >98% 6.636961325967 carbocyclic-thromboxane-a2 CTA2; Carbocyclic TXA2 thromboxanes analogs TXA2 vasoconstriction CTA2 atherosclerosis 6.636961325967
13187 Cardiogenol C (hydrochloride) 671225-39-1 ≥97% 2009-02-06 3.536022099447 cardiogenol-c-hydrochloride Embryonic stem cells Differentiation Cardiomyocytes Cardiac muscle GATA-4 MEF2 Nkx2.5 3.536022099447
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 119.233397790055 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis 119.233397790055
10005913 CAY10449 Exclusive - >98% ✓ 2004-10-26 93.114659300184 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 93.114659300184
10006482 CAY10485 615264-62-5 >98% 2005-05-03 5.100134175217 cay10485 3,4-dihydroxy Hydrocinnamic acid (L-Aspartic acid dibenzyl ester) amide atherosclerosis antioxidants dihydrocinnamic acids LDLs low density lipoproteins cholesterols acyl-coenzyme A: cholesterol acyltransferase-1 catalyzes esters ACAT-1 ACAT-2 low density lipoproteins oxidations ACAT1 ACAT2 5.100134175217
10006452 CAY10486 615264-52-3 >98% 2005-05-09 5.732348066298 cay10486 4-Hydroxycinnamic acid (L-phenylalanine methyl ester) amide atherosclerosis antioxidants dihydrocinnamic acids LDLs cholesterols acyl-coenzyme A:cholesterol acyltransferase-1 catalyzes esters ACAT-1 ACAT-2 low density lipoproteins oxidations ACAT1 ACAT2 5.732348066298
10006480 CAY10487 778624-05-8 >98% 2005-03-29 5.732348066298 cay10487 3,4-Dihydrocinnamic Acid (L-alanine methyl ester) amide atherosclerosis antioxidants dihydrocinnamic acids LDLs cholesterols low-density lipoproteins foam cells fatty streaks arterial walls lesions thoracic aortas lipids ACAT-1 ACAT-2 ACAT1 ACAT2 5.732348066298
10007875 CAY10499 Exclusive 359714-55-9 >98% ✓ 2006-07-25 9.754143646408 cay10499 obesity lipases diabetes triglycerides diacylglycerol inhibitors steroidogenesis spermatogenesis atherosclerosis HSL hormone sensitive endocrinology 9.754143646408
10009536 CAY10512 Exclusive 139141-12-1 >97% ✓ 2007-07-18 34.820911602210 cay10512 analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis 34.820911602210
10009017 CAY10514 868526-38-9 >98% 2007-01-24 3.998232044199 cay10514 Methyl-8-hydroxy-8-(2-pentyl-oxyphenyl)-oct-5-ynoate peroxisome proliferator-activated receptors aromatics analogs 8-HETEs 8S-HETE 8(S)-HETE agonists PPARa PPARalpha PPAR.alpha. PPARg PPARgamma PPAR.gamma.atherosclerosis 3.998232044199
16835 CAY10580 Exclusive 64054-40-6 ≥96% ✓ 2009-03-16 77.547532228361 cay10580 PGEs PGE2 receptors inhibitors inhibits inhibition antagonist blockers EP4 cAMPs bones fromation resorption cancers atherosclerosis 77.547532228361
10012424 CAY10583 Exclusive 862891-27-8 ≥98% ✓ 2009-07-21 63.267826887661 cay10583 LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation 63.267826887661
13181 CAY10590 Exclusive 1101136-50-8 ≥98% ✓ 2009-04-15 15.854451460142 cay10590 sPLA2 cPLA2 iPLA2 phospholipases inhibitors R-gamma-nonleucine inhibition inhibited secreetory regulates phagocytosis foam cells 15.854451460142
10012536 CAY10592 Exclusive 685139-10-0 ≥98% ✓ 2009-02-26 39.451790055248 cay10592 selective PPARδ agonist HDLs LDLs TGs lipids metanolism plasma rats L6 cells lines APOB100 CETP-Tgn mice mouse transactivation assays CETPTgn CETP Tgn 39.451790055248
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 73.670928176795 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 73.670928176795
13282 CAY10599 Exclusive 1143573-33-4 ≥98% ✓ 2009-07-21 47.998624923265 cay10599 thiazolidinedione PPARs PPARγ agonist rosiglitazones BRL 49653 BRL49653 BRL-49653 diabetes TZDs 47.998624923265
10804 CAY10649 Exclusive - ≥98% ✓ 2011-04-04 18.383052005167 cay10649 5-LO leukotrienes 5-lipoxygenases inhibitors inflammation smooth muscle contraction inhibition inhibited PMNL inflammatory 18.383052005167
188150 CD36 Monoclonal Antibody (Clone JC63.1) - 22.515937101572 cd36-monoclonal-antibody-clone-jc63-1 Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb antibodies antisera antiserum flow cytometry PPAR.gamma. CD-36 glycoprotein fatty acids PPARgamma blocking apoptosis oxidative injury atherosclerosis FC 22.515937101572
10009893 CD36 Monoclonal Antibody (Clone JC63.1) (azide free) Exclusive - ✓ 2010-03-03 21.251712707181 cd36-monoclonal-antibody-clone-jc63-1-azide-free GPIIIb; Hexarelin Receptor; Thrombospondin Receptor; oxLDL; GPIV antibodies antisera antiserum flow cytometry PPAR.gamma. CD-36 glycoprotein fatty acids PPARgamma blocking apoptosis oxidative injury atherosclerosis FC leukemia lymphocytic 21.251712707181
10009870 CD36 Monoclonal FITC Antibody (Clone JC63.1) - 2008-03-17 50.304014732965 cd36-monoclonal-fitc-antibody-clone-jc63-1 Thrombospondin Receptor; Hexarelin Receptor; GPIIIb; OxLDL Receptor; GPIV type-B atherosclerotic lesions fatty acids PPAR.gamma. expression flow cytometry immunocytochemistry FC ICC IF immunofluorescence 50.304014732965
100011 CD36 Polyclonal Antibody - 34.725257826887 cd36-polyclonal-antibody Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb type scavengers receptors atherosclerotic lesions glycoprotiens membranes PPAR.gamma. PPARgamma antibodies atherosclerosis CD-36 western blots blotting peroxisome proliferator-activated GP-IIIb GP-IV GP-3b GP-4 WB atherosclerosis immunoblotting 34.725257826887
10010250 Cellular Retinol Binding Protein 7 Polyclonal Antibody - 2007-10-16 4.740928176795 cellular-retinol-binding-protein-7-polyclonal-antibody Retinoid Binding Protein 7; cRBP7; RET7; Cellular Retinol Acid-Binding Protein IV western blots WB ICC immunocytochemistry micronutrient cell growth differentiation CRBPs RBP4 RBP7 atherosclerosis blotting immunoblotting IHC immunohistochemistry 4.740928176795
10007171 Cetaben 55986-43-1 ≥98% 2005-11-11 1.833767955800 cetaben Hexadecylamino-p-amino Benzoic Acid clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology 1.833767955800
10012447 CG 4305 - ≥95% 2010-05-12 50.951981057616 cg-4305 antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 50.951981057616
10325 Chemokine-Like Receptor 1 Polyclonal Antibody - 2010-01-25 65.399367710251 chemokine-like-receptor-1-polyclonal-antibody Resolvin E1 Receptor; GPCR ChemR23; ChemerinR; DEZ; CMKLR1; ChemR23 immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR 65.399367710251
10011286 Chenodeoxycholic Acid 474-25-9 ≥95% 2009-02-25 26.271690607734 chenodeoxycholic-acid Ulmenide; Kebilis; Anthropodeoxycholic Acid; Hekbilin; Fluibil; CDCA FXR biles acids cholesterol oxidative stress glutathione cancers atherosclerosis diabetes hyperlipidemia CDA 26.271690607734
10007640 Cholesterol Assay Kit - 2006-02-28 130.915453605490 cholesterol-assay-kit Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis assays fluorescent fluorometric 130.915453605490
10009779 Cholesterol Cell-Based Detection Assay Kit - 2007-05-04 57.098345374698 cholesterol-cell-based-detection-assay-kit Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis fluorescent fluorometric assays cell-based assay cell based assays cba U18666A U 18666A U-18666A 57.098345374698
600440 Cholesterol Uptake Cell-Based Assay Kit - 2011-06-28 38.823346963406 cholesterol-uptake-cell-based-assay-kit assays kits measures measurements cells hormones intermediates bile acids biosynthesis body cholesterols homeostasis de novo dietary absorption biliary clearance excretion plasma hypercholesterolemia cardiovascular diseases serum hepatic Ezetimibe inhibitors inhibits inhibition intestinal uptake enterocytes proteins Niemann-Pick C1 Like 1 NPC1L1 genes influx efflux intraluminal molecules membranes modulators NBD cultured U18666A inhibitor inhibits inhibition positive controls U 18666A U-18666A 38.823346963406
48001 Cholesteryl Linoleate Hydroperoxides - >98% hydroperoxide content 13.910419889502 cholesteryl-linoleate-hydroperoxides autoxidation atherosclerosis LDL HDL hydroperoxy fatty acids 13.910419889502
10010060 ChREBP Cell-Based Translocation Assay Kit - 2007-08-15 13.247209944751 chrebp-cell-based-translocation-assay-kit Carbohydrate Response Element-Binding Protein Cell-Based Translocation Assay Kit assays kits transcription factors TFs diabetes nutrients hormones hormonal regulation genes encoding enzymes glucose metabolisms lipogenesis dephosphorylated cytoplasm protein Ser196 nucleus liver obesity tolerance drugs discovery modulators sub-cellular localization ICC immunocytochemical stains staining antibody antibodies DyLightTM Pierce Biotechnology Inc. fluorescence fluorescent fluorometric endocrinology cell-based assay cell based assay cba 13.247209944751
10006909 ChREBP Transcription Factor Assay Kit - 2006-07-12 39.521702183635 chrebp-transcription-factor-assay-kit Carbohydrate Response Element-Binding Protein tf chrebps carbohydrate response element binding protein glucose liver insulin obesity adipokines endocrinology assays 39.521702183635
71730 Ciglitazone 74772-77-3 ≥98% 56.195560020090 ciglitazone U-63287; ADD 3878 nuclear receptors antidiabetic diabetes thiazolidinedione PPAR gamma PPAR.gamma. Peroxisome Proliferator-activated receptors Ligands Binding domains antihyperglycemic atherosclerosis endocrinology 56.195560020090
18216 Ciprostene (calcium salt) 81703-55-1 ≥98% 51.273157659187 ciprostene-calcium-salt U-61431F; Ciprostene calcium PGI2 analogs vasodilation 9.beta.-methyl 9beta-methyl carbaprostacyclin prostaglandins salts cat U61431F atherosclerosis 51.273157659187
10004235 cis-Resveratrol 61434-67-1 >98% (may contain 1-5% trans) 2008-02-05 27.162389502762 cis-resveratrol (Z)-Resveratrol antioxidant oxidative stress reactive oxygen species reactive nitrogen species ROS RNS NF-kb inflammations monoamine oxidase noradrenaline inhibits inhibitor inhibitions NF.kappa. atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors 27.162389502762
10956 Clofibrate 637-07-0 ≥98% 2004-09-14 20.854229588704 clofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate 20.854229588704
160110 COX-1 Monoclonal Antibody (Clone CX111) - 44.420428176795 cox-1-monoclonal-antibody-clone-cx111 PGHS-1; Prostaglandin H Synthase 1; Cyclooxygenase 1 prostaglandins inflammation cancer arthritis antibodies cox1 pghs1 pghs-1 synthases cyclooxygenases western blots blotting WB antisera antiserum immunohistochemistry IHC immunocytochemistry ICC antisera antiserum atherosclerosis immunoblotting 44.420428176795
160109 COX-1 (mouse) Polyclonal Antibody - 38.133563535911 cox-1-mouse-polyclonal-antibody PGHS-1; Prostaglandin H Synthase 1; Cyclooxygenase 1 prostaglandins inflammation cancer arthritis antibodies mouse cox1 pghs1 pghs-1 cyclooxygenase-1 cyclooxygenases synthase-1 synthases antiserum antisera western blots blotting wb IHC immunohistochemistry atherosclerosis immunoblotting 38.133563535911
10011236 C-Reactive Protein (human) EIA Kit - 2009-04-22 292.398823204420 c-reactive-protein-human-eia-kit CRP (human) EIA Kit atherosclerosis proteins hepatocytes adipocytes plasma blood inflammatory inflammation physiological pathological atherogenesis endothelial coagulation ICAM-1 VCAM-1 E-selectin LDL macrophages plaques immunometric assays enzyme immunoassay ELISAs 292.398823204420
120500 CysLT1 Receptor Polyclonal Antibody - 53.769629834254 cyslt1-receptor-polyclonal-antibody Cysteinyl Leukotriene Receptor 1 cysteinyl-leukotrienes receptors antibodies LTC4 LTD4 LTE4 Cys-LT1 human flow cytometry asthma peptido-leukotrienes FACS antisera immunochemistry icc immunohistory ihc antiserum wb western blotting blots atherosclerosis immunoblotting immunocytochemistry immunohistochemistry FC 53.769629834254
13202 Daidzin New 552-66-9 ≥98% 2011-09-30 3.056718891729 daidzin NPI 031D; Daidzoside isoflavones soy kudzu anti-oxidants cancers oxidants stress atherosclerosis inhibitor inhibits inhibition mitochondrial aldehydes dehydrogenases 2 alcohols plants anticarcinogenic anti-carcinogenic anti carcinogenic antioxidants antidipsotropic dipsotropic anti-dipsotropic anti-atherosclerosis antiatherosclerosis atherosclerosis 1329-08-4 28572-56-7 NPI-031D NPI031D 7-glucoside glucosides 3.056718891729
10012577 Diallyl Trisulfide 2050-87-5 ≥98% 2009-04-07 20.051926335174 diallyl-trisulfide DATS; NSC 651936 garlic hydrogen sulfides H2S cancers tumors smooth muscle cholesterol atherosclerosis donors supresses colon synthesis genes expression adenocarcinomas HCT-15 cells PC-3 xenografts 20.051926335174
62237 Diphenyl-1-pyrenylphosphine 110231-30-6 ≥98% 2006-07-25 80.386255371393 diphenyl-1-pyrenylphosphine DPPP hydroperoxides oxidative stress injury fluorescence fluorescent lipids cholesterols LDL oxidation DPPPO DPPP=O atherosclerosis 80.386255371393
10005057 Docosahexaenoic Acid-d5 - ≥99% deuterated product 2005-03-16 202.916675874770 docosahexaenoic-acid-d5 DHA-d5; Cervonic Acid-d5 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension 202.916675874770
9090310 Docosahexaenoic Acid ethyl ester 1020718-25-5 ≥98% 2009-01-15 60.934944751381 docosahexaenoic-acid-ethyl-ester DHA ethyl ester; Cervonic Acid ethyl ester fish oils anti-inflammatory antiiflammatory cardiovascular polyunsaturated fatty acids PUFAs DHAs neural tissues retina brain learning diet nutrition oxidation vision liver function muscle tone competitive inhibitors inhibits inhibition metabolism 60.934944751381
101640 DP1 Receptor Polyclonal Antibody - 2004-10-22 21.396132596684 dp1-receptor-polyclonal-antibody Prostaglandin D2 Receptor 1; PGD2 Receptor 1 isoforms prostaglandins PGs PGD2 cyclooxygenase metabolites G-protein coupled receptors GPCR cyclic cAMP Ca2+ calcium western blots blotting WB immunocytochemistry ICC immunohistochemistry IHC COX antibodies antiserum antisera atherosclerosis immunoblotting 21.396132596684
10011296 (E)-Guggulsterone 39025-24-6 ≥98% 2009-12-03 0.966850828729 -e-guggulsterone anti-flammatory cancers FXR bile acids LDL cholesterol antiinflammatory atherosclerosis obesity diabetes inflammation farnesoid X receptors guggul trees 0.966850828729
10008884 Eicosapentaenoic Acid ethyl ester 86227-47-6 ≥98% 2009-01-29 56.566645930308 eicosapentaenoic-acid-ethyl-ester EPA-EE; EPA ethyl ester fish oils anti-inflammatory anitinflammatory cardiovascular polyunsaturated fatty acids PUFAs EPAs nutrition oxidation competitive inhibitors inhibits inhibition metabolism cholesterol triglycerides insulin resistance adiponectin high fat diet high-fat TNFα 56.566645930308
100030 Endothelial Lipase Polyclonal Antibody - 2004-01-05 5.646235727440 endothelial-lipase-polyclonal-antibody EDL; EL antibodies antisera antiserum western blots blotting wb icc immunocytochemistry atherosclerosis special:month specialdiscount:15 specialstart:2008-03-01 specialend:2008-03-31 immunoblotting IHC immunohistochemistry 5.646235727440
583151 Endothelin EIA Kit - 201.414640883978 endothelin-eia-kit ET EIA Kit; Endothelin ELISA Kit atherosclerosis ET-1 vascular vasoconstriction measures kits eias enzyme immunoassays ELISAs endocrinology assays 201.414640883978
60880 eNOS (bovine recombinant) - cell lysate 100,000 x g supernatant 23.990649171271 enos-bovine-recombinant ecNOS; NOS III; Endothelial Nitric Oxide Synthase endothelial enzymes nitric oxide synthases cow atherosclerosis 23.990649171271
360880 eNOS Electrophoresis Standard - >95% 5.265469613259 enos-electrophoresis-standard ecNOS; NOS III; Endothelial Nitric Oxide Synthase standards western blots blotting gels staining WB synthases polyacrylamide NOS-3 atherosclerosis 5.265469613259
160880 eNOS Polyclonal Antiserum - 12.384723756906 enos-polyclonal-antiserum ecNOS; NOS III; Endothelial Nitric Oxide Synthase synthases Western blots cells EDRF vasculature antisera blotting WB antibodies antiserum atherosclerosis immunoblotting IP immunoprecipitation 12.384723756906
10477 EP2 Receptor Polyclonal PE Antibody - 2010-07-07 24.681933701657 ep2-receptor-polyclonal-pe-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons 24.681933701657
10010019 FABP2 Polyclonal Antibody - 2007-10-02 22.575615627466 fabp2-polyclonal-antibody I-FABP; Intestinal-Fatty Acid Binding Protein; Fatty Acid Binding Protein 2 WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting 22.575615627466
10233 FABP3 Monoclonal Antibody (Clone CC68) - 2009-03-20 8.984487415591 fabp3-monoclonal-antibody-clone-cc68 Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting 8.984487415591
10007614 FABP4 (human) EIA Kit - 2006-10-13 15.635333333333 fabp4-human-eia-kit Fatty Acid Binding Protein 4 (human) EIA Kit; Adipocyte FABP (human) EIA Kit; A-FABP (human) ELISA Kit; aP2 10009284 SPI-BIO spibio ELISA immunoassay enzyme A05181 FABP4 fatty acid binding protein adipocytes aP2 atherosclerosis endocrinology assays 15.635333333333
10009549 FABP4 (human recombinant) - >90% 2007-06-15 30.360148746281 fabp4-human-recombinant Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; A-FABP; Adipocyte Fatty Acid Binding Protein; aP2 cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology 30.360148746281
9001068 FABP4 (human recombinant) FITC conjugated New - ≥95% 2011-08-23 11.593022888713 fabp4-human-recombinant-fitc-conjugated ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4 fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 11.593022888713
10010463 FABP4 (human recombinant) Western Ready Control - 2007-10-23 5.106180939226 fabp4-human-recombinant-western-ready-control Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting 5.106180939226
10010231 FABP4 Inhibitor/Ligand Screening Assay Kit - 2007-11-01 23.683769655758 fabp4-inhibitor-ligand-screening-assay-kit aP2; Adipocyte FABP; A-FABP; Fatty Acid Binding Protein 4 fabps kits atherosclerosis assays fatty acid binding protein adipocytes aP2 cytosolic lipophilic ligands uptake metabolisms cellular membranes intracellular trafficking cells growth differentiation PPARg PPARgamma PPAR.gamma. peroxisomes proliferator-activated receptors agonists insulin genes deletion mice mouse murine chronic metabolic diseases diabetes atherosclerosis fluorescence fluorescent fluorometric endocrinology 23.683769655758
10005191 FABP4 (mouse recombinant) - >95% 2005-07-27 10.065867403314 fabp4-mouse-recombinant Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology 10.065867403314
10009676 FABP4 (mouse recombinant) Western Ready Control - 2007-04-30 4.295814917127 fabp4-mouse-recombinant-western-ready-control ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis 4.295814917127
10004944 FABP4 Polyclonal Antibody - 2004-11-05 12.553962115233 fabp4-polyclonal-antibody Fatty Acid Binding Protein 4; aP2; A-FABP; ALBP; Adipocyte-FABP atherosclerosis adipocytes macrophages 3T3-L1 fatty acids PPAR.gamma. PPARgamma agonists insulin WB western blots blotting ICC immunocytochemistry hyperinsulinemia deficiency antibodies antiserum antisera endocrinology immunoblotting 12.553962115233
10010364 FABP5 (human recombinant) - >95% 2007-08-08 16.979712707182 fabp5-human-recombinant Keratinocyte FABP; Psoriasis-Associated FABP; Fatty Acid Binding Protein 5; Epidermal-FABP; E-FABP; DA11 FABP proteins lipophilic ligands uptake metabolism cellular membranes FABP-5 FABPs cytosolic fatty acids bladders carcinoma prostates atherosclerosis endocrinology 16.979712707182
10007433 FABP5 (mouse recombinant) - >95% 2005-07-29 6.411692616775 fabp5-mouse-recombinant Epidermal-FABP; Fatty Acid Binding Protein 5; E-FABP protein-only proteins cytosolic acids lipophilic ligands uptake metabolism cellular membranes intracellular trafficking modulation enzymes lipids metabolic pathways cells growth differentiation antiparallel B .beta. strands barrel prostates bladder carcinomas atherosclerosis endocrinology neurochemistry 6.411692616775
10010501 Farnesyl Thiosalicylic Acid 162520-00-5 ≥96% 2008-06-02 21.011473296501 farnesyl-thiosalicylic-acid Salirasib; FTS ras inhibitors inhibition inhibits cancer anti-cancer anticancer prenylation farnesylation signal transduction oncogene atherosclerosis farnesylthiosalicylic acid 21.011473296501
10005368 Fenofibrate 49562-28-9 ≥98% 2004-09-15 22.251700429711 fenofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology 22.251700429711
70440 Filipin III 480-49-9 ≥85% 42.909668508287 filipin-iii Filipin-3 Filipin-III Cholesterol fluorescent fluorescence atherosclerosis filipin 111 42.909668508287
10010337 Fluvastatin (sodium salt) 93957-55-2 ≥98% 2008-02-27 12.218204419889 fluvastatin-sodium-salt atherosclerosis HMG-CoA reductases LDL LDL-c HDL HDL-c statin cholesterol heart disease CVD inhibitors inhibits inhibition 12.218204419889
10039 FR122047 (hydrate) - ≥98% 9.722624309392 fr122047-hydrate 130717-51-0 FR-122047 cyclooxygenases COX-1 inhibitors hydrates hydrochlorides COX1 PGHS1 PGHS-1 prostaglandin synthases inhibition inhibits selective selectivity platelet aggregation antiinflammatory atherosclerosis 9.722624309392
70540 Furegrelate (sodium salt) 85666-17-7 ≥99% 1.726537753222 furegrelate-sodium-salt U-63557A thromboxanes synthases inhibitors inhibits inhibition salts atherosclerosis 1.726537753222
10006798 GW 0742 317318-84-6 ≥98% 2007-07-25 20.800607734806 gw-0742 PPAR PPAR.beta. PPAR.delta. peroxisome proliferator activated receptor neurotoxicity agonists neuroprotection toxicity apoptosis lipids metabolism atherosclerosis endocrinology GW0742 GW-0742 20.800607734806
10009880 GW 590735 Exclusive 622402-22-6 ≥98% ✓ 2007-06-18 5.925966850829 gw-590735 PPAR PPAR.alpha. PPAR.BETA. PPAR.gamma. PPAR.delta. receptor transcription factors lipidtriglyceride TG lipoprotein VLDL ApoCIII ApoA1 HDL atherosclerosis endocrinology 5.925966850829
10008613 GW 7647 265129-71-3 ≥98% 2006-08-02 16.717079715863 gw-7647 PPAR.alpha. peroxisome proliferator-activated receptor triglycerides lipid homeostasis transcription factor fibrate atherosclerosis endocrinology GW7647 16.717079715863
10011211 GW 9578 Exclusive 247923-29-1 ≥98% ✓ 2008-05-23 23.362681682957 gw-9578 atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated 23.362681682957
70785 GW 9662 22978-25-2 ≥98% 87.012878453038 gw-9662 GW-9662 GW9662 ligands ppar.gamma. ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis 87.012878453038
9000497 GW 9662-d5 Exclusive - ≥99% deuterated product ✓ 2009-09-30 44.903296500920 gw-9662-d5 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry GW-9662 GW9662 ligands ppar.gamma. γ ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis TZDs thiaolidinediones PPARs 44.903296500920
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 68.667826887661 ha-1077-hydrochloride Eril; Fasudil; AT-877 protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 68.667826887661
10006084 Hesperetin 520-33-2 ≥98% 2005-02-16 10.879016574585 hesperetin hesperitin hesperidin atherosclerosis citrus nutraceuticals flavonoids flavanoids hypocholesterolemic ACAT2 ACAT-2 mRNA transcription inhibits inhibition inhibitors ApoB proteins histamines azelastine atherosclerosis 10.879016574585
13354 Hexacosanoic Acid 506-46-7 ≥98% 2009-07-24 12.509677554844 hexacosanoic-acid Cerotic Acid; Ceric Acid; NSC 4205 fatty acids very long chain very-long-chain peroxisomes peroxisomals disorders adrenoleukodystrophy atherosclerosis metabolic syndromes red blood cells plasma ceratinic acids cerinic cerylic n-hexacosanoic 12.509677554844
10006371 Hormone Sensitive Lipase Polyclonal Antibody - 2005-06-22 8.847826887661 hormone-sensitive-lipase-polyclonal-antibody HSL; LIPE proteins antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry catalyses hydrolysis of tri- di- monoacylglycerols cholesterol esters mobilizes fatty acids primary source energy mammals enzyme expressed adipose tissues stearidonic steroidgenesis spermatogenesis foam cell formation atherosclerosis diabetic pathology human cDNA isoforms testis mRNA mouse murine macrophages testicular ram seminal vesicles triacylglycerols diacylglycerols atherosclerosis 8.847826887661
10699 HTS 01037 682741-29-3 ≥98% 2011-03-14 15.947182320442 hts-01037 adipocytes fatty acids binding proteins FABP4 AFABP A-FABP aP2 macrophages lipocytes diabetes atherosclerosis HTS-01037 HTS01037 Isomerases Amino Acid Acid Isomerases Amino Racemases Amino Acid Amino Acid Isomerases Acid Racemases Amino Amino Acid Racemases 15.947182320442
18215 Iloprost 78919-13-8 ≥97% 134.543953345610 iloprost Ciloprost agonists IP receptors vasodilator hypostensive atherosclerosis antiduretic hypertension analogs PGI2 prostaglandins prostacyclin selective selectivity pharma:21 134.543953345610
10809 Interleukin-33 (human) Monoclonal Antibody (Clone IL33305B) - 2011-06-03 0E-12 interleukin-33-human-monoclonal-antibody-clone-il33305b IL-1F11; NF-HEV; IL-33 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10811 Interleukin-33 Monoclonal Antibody (Clone IL33026B) - 2011-06-02 0E-12 interleukin-33-monoclonal-antibody-clone-il33026b IL-33; NF-HEV; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10810 Interleukin-33 Monoclonal Antibody (Clone IL333068A) - 2011-06-02 0E-12 interleukin-33-monoclonal-antibody-clone-il333068a IL-33; NF-HEV; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10005518 IP Receptor (human) Polyclonal Antibody - 2004-10-21 24.633523634131 ip-receptor-human-polyclonal-antibody Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis 24.633523634131
160070 IP Receptor (mouse) Polyclonal Antibody - 2004-05-25 23.623009208102 ip-receptor-mouse-polyclonal-antibody PGI2 Receptor; Prostacyclin Receptor; Prostaglandin I2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors atherosclerosis neurochemistry immunoblotting 23.623009208102
19021 I-SAP 133538-58-6 ≥98% 5.328176795580 i-sap Iodophenyl sulfonyl amino pinane Thromboxane A2; Iodophenyl sulfonyl amino pinane TXA2 thromboxanes ISAP pinane analogs agtagonists TP receptors atherosclerosis 5.328176795580
10011054 KB2115 Exclusive 355129-15-6 ≥98% ✓ 2008-06-10 75.448066298342 kb2115 thyroid hormones dyslipidemia LDL cholesterol statins cardiovascular disease atherosclerosis obesity 75.448066298342
62935 KDdiA-PC Exclusive 439904-34-4 >98% ✓ 2005-09-09 8.889740756480 kddia-pc CD36 ligands oxidized oxLDL low density lipoproteins particles cytotoxics pro-atherogenic phosphatidylcholines species short-chain fatty acids sn-2 scavengers receptors structural determinants binding affinity atherosclerosis 8.889740756480
62945 KOdiA-PC Exclusive 439904-33-3 >98% ✓ 2004-01-28 40.892470402525 kodia-pc oxidative injury lipids oxLDL oxidized low-density lipoproteins phosphatidylcholines CD36 CD-36 scavengers receptors binding atherosclerosis 40.892470402525
10009324 LCAT Blocking Peptide - 2007-01-03 21.612658839778 lcat-blocking-peptide Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol-O-Acyltransferase antibodies western blotting blots signaling signalling WB controls peptides proteins cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary 21.612658839778
10009323 LCAT Polyclonal Antibody - 2007-01-03 20.924389195825 lcat-polyclonal-antibody Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol O-Acyltransferase proteins diseases antibodies antisera antiserum WB western blots blotting cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary atherosclerosis immunoblotting 20.924389195825
10007672 LDL Receptor Blocking Peptide - 2007-05-03 8.345138121547 ldl-receptor-blocking-peptide Low-density Lipoprotein Receptor Blocking peptide; LDLR Blocking Peptide proteins diseases WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic livers hormonal controls mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 8.345138121547
10007665 LDL Receptor Polyclonal Antibody - 2006-02-15 30.449125630554 ldl-receptor-polyclonal-antibody LDLR; Low Density Lipoprotein Receptor proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic tails livers hormonal controls in vivo vitro mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 cell-based assay cell based assay cba immunoblotting 30.449125630554
10011125 LDL Uptake Cell-Based Assay Kit - 2008-04-29 36.676138668359 ldl-uptake-cell-based-assay-kit Low-Density Lipoprotein Uptake atherosclerosis cholestrols plasmas blood coronary heart diseases low-density lipoproteins kits assays assaying tools uptakes regulation 36.676138668359
10007817 Leukotriene A4 Hydrolase (human recombinant) - >90% 2005-12-14 257.451246163290 leukotriene-a4-hydrolase-human-recombinant LTA4H leukotrienes bifunctional zinc metalloenzymes converts LTB4 neutrophils chemoattractants hydrolases activity anion-dependent aminopeptidases drugs leukocytes infiltration inflammation E. coli epoxides atherosclerosis 257.451246163290
20110 Leukotriene B4 71160-24-2 ≥97% 184.036077348066 leukotriene-b4 LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis 184.036077348066
320110 Leukotriene B4-d4 - ≥99% deuterated product 133.897044198895 leukotriene-b4-d4 LTB4-d4 GC/MS LTB4-d4 deuterium internal standards isotopes leukotrienes GC-MS mass spectrometry LC/MS LC-MS deuterated spectroscopy atherosclerosis mass spectrometry 133.897044198895
520111 Leukotriene B4 EIA Kit - 844.331602209944 leukotriene-b4-eia-kit Leukotriene B4 ELISA Kit solid plates neutrophils 5-LOs 5-lipoxygenases LTB4 measures kits atherosclerosis eias enzyme immunoassays ELISAs leukotrienes assays 844.331602209944
10007240 Leukotriene B4 Lipid Maps MS Standard 71160-24-2 ≥97% 2009-01-14 32.633635359115 leukotriene-b4-lipid-maps-ms-standard LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards 32.633635359115
520411 Leukotriene E4 EIA Kit - 184.709185082873 leukotriene-e4-eia-kit Leukotriene E4 ELISA Kit solid plates kitrecommendation:cyslt allergy cys-LTs cysteinyl-leukotrienes atherosclerosis neutrophils LTE4 measures kits eias enzyme immunoassays ELISAs asthma cysteinyl-LTs peptido-LTs peptido-leukotrienes assays 184.709185082873
89430 Linolein Hydroperoxides - >98% (A mixture of 132 isomers) 11.499815837937 linolein-hydroperoxides trilinoleins autoxidation atherosclerosis isomers hydroperoxy fatty acids 11.499815837937
705002 Lipid Hydroperoxide (LPO) Assay Kit - 259.771404419889 lipid-hydroperoxide-lpo-assay-kit lipids peroxidation oxidative injury inflammation free radicals colorimetric hydroperoxides stress atherosclerosis assays 259.771404419889
705003 Lipid Hydroperoxide (LPO) Assay Kit (96 well) - 156.447859116022 lipid-hydroperoxide-lpo-assay-kit-96-well lipids peroxidation oxidative injury inflammation free radicals colorimetric hydroperoxides stress assays 156.447859116022
10010338 Lovastatin 75330-75-5 >98% 2008-03-03 7.865388865278 lovastatin LDL-c cholesterol HMG-CoA reductase HMGCoA statins heart diseases CVD atherosclerosis HDL-c NF-kB NF-.kappa.B TNF-.alpha. apoptosis anti-cancer mevacor Altocor mevinolin inhibits inhibitors inhibition 7.865388865278
10010339 Lovastatin Hydroxy Acid (sodium salt) Exclusive - >98% ✓ 2008-03-04 8.833895027624 lovastatin-hydroxy-acid-sodium-salt atherosclerosis LDL cholesterol HMG-CoA reductase statin heart disease CVD LDL-c HDL HDL-c inhibitors inhibits inhibition 8.833895027624
10010971 Luminex® 11-dehydro Thromboxane B2 Kit - 2008-01-24 89.828657151627 luminex-11-dehydro-thromboxane-b2-kit Luminex® 11-dehydro TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays 89.828657151627
10010228 Lyso-PAF C-18 -d4 Exclusive - ≥99% deuterated product ✓ 2010-11-03 10.797270718231 lyso-paf-c-18-d4 PAFs platelet-activating factors deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 10.797270718231
10010497 Manumycin A 52665-74-4 ≥98% 2008-06-25 19.969640883978 manumycin-a UCF 1C; NSC 622141 farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB 19.969640883978
90290 MEDICA 16 87272-20-6 >98% 15.703287292818 medica-16 hypolipidemic antidiabetogenic analogs fatty acids diabetes antidiabetic b,b'-hexadecanedioic nuclear receptors beta,beta-hexadecanedioic .beta.,.beta.'-hexadecanedioic VLDL decrease atherosclerosis 15.703287292818
600160 Methionine Sulfoxide Immunoblotting Kit - 2009-12-17 208.421613259668 methionine-sulfoxide-immunoblotting-kit MetO Immunoblotting Kit proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 208.421613259668
10010340 Mevastatin 73573-88-3 ≥98% 2008-07-16 15.453029465930 mevastatin CS 500; ML 236B; Compactin; L 637312; NSC 281245; Statin I atherosclerosis cholesterol HMG-CoA reductases statins heart diseases CVD LDL-c LDLc HDL-c HDLc TNF-.alpha. TNF-a TNF-alpha NF-kb NF-.kappa.B NF-kappaB apoptosis cancers cardiovascular TNF.alpha. inhibtis inhibitor inhibition HMGCoA pythium ultimum 15.453029465930
10006438 Myeloperoxidase Chlorination Assay Kit - 2009-04-14 118.434392265193 myeloperoxidase-chlorination-assay-kit MPO Chlorination Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes APF 2-[6-(4-aminophenoxy)-3-oxo3H-xanthen-9-yl]-benzoic acid hypochlorite -OCl 118.434392265193
10012600 Myricetin 529-44-2 >98% 2009-02-20 15.424088397790 myricetin NSC 407290; Cannabiscetin flavonoid antioxidant oxLDL CD36 atherosclerosis cancers JAK1 STAT3 MEK1 15.424088397790
63150 Myriocin 35891-70-4 >98% 2007-05-03 49.891958256598 myriocin Thermozymocidin; ISP-1 serine palmitoyltransferase inhibitors sphingolipids antibiotic immunosuppressants inhibition inhibited atherosclerosis 49.891958256598
13055 Naphthofluorescein 61419-02-1 ≥98% 2009-03-20 0.670534069981 naphthofluorescein CCG 8295 furin matrix metalloproteinase MTA-MMP MMP2 motility invasion cancer metastasis MMP inhibitors naphthafluorescein 0.670534069981
80230 NG,NG-dimethyl-L-Arginine (hydrochloride) 220805-22-1 >98% 21.839403314917 ng-ng-dimethyl-l-arginine-hydrochloride ADMA endogenous nitric oxide synthase inhibitors NOS renal failure preeclampsia inhibits inhibition asymmetric dimethylarginine hypercholesterolemia atherosclerosis muscular dystrophy 21.839403314917
189542 Nitrotyrosine Monoclonal Antibody - 40.785649171270 nitrotyrosine-monoclonal-antibody peroxynitrite nitric oxide superoxide oxidative injury stress Alzheimer's diseases antibodies NO western blots blotting WB nitration proteins antisera antiserum IHC immunohistochemistry immunoprecipitation IP atherosclerosis immunoblotting EIA enzyme immunoassays 40.785649171270
10009661 N-Octadecyl-N'-propyl-sulfamide - >95% 2008-04-23 5.341961325967 n-octadecyl-n-propyl-sulfamide PPAR.alpha. PPARa PPARalpha OEA satiety obesity metabolism food intake triglyceride lipids activators appetite suppression 5.341961325967
10010411 NS-304 475086-01-2 >98% 2008-04-09 41.397650158956 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs 41.397650158956
10006782 Oleic Acid-2,6-diisopropylanilide 140112-65-8 >98% 2005-05-18 1.986552486188 oleic-acid-2-6-diisopropylanilide HDL LDL cholesterols ACAT inhibitors ODA acylCoA:cholesterol acyltransferase intracellular cholesteryl esters synthases dietary inhibits low-density liproteins high-density inhibition atherosclerosis 1.986552486188
10006529 Oleyl Anilide 5429-85-6 >95% 2005-05-18 2.062342541436 oleyl-anilide OA; Oleic Acid Anilide HDL LDL cholesterols ACAT inhibitors ODA acylCoA:cholesterol acyltransferase intracellular cholesteryl esters synthases dietary inhibits glycerides dioleoyl phenylamino propane 1,2-diols eosinophilia excessive T cell activation acute pulmonary inflammatory reactions TOS toxic oil syndrome aniline-denatured cooking oils interleukins atherosclerosis 2.062342541436
600240 Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 0.869820441989 orexin-1-receptor-step-reporter-assay-kit-luminescence OX1R hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 0.869820441989
600250 Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 1.019337016574 orexin-2-receptor-step-reporter-assay-kit-luminescence OX2R hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 1.019337016574
34004 Oxidized Lipid HPLC Mixture - >98% for each compound 17.747636586863 oxidized-lipid-hplc-mixture ROS peroxidation LDL atherosclerosis autoxidation reactive oxygen species (+/-)9-HODEs (+/-)13-HODEs esters (+/-)15-HETEs (+/-)-HODEs (+/-)-HETEs hydroxy fatty acids racemic (+/-)HODEs (+/-)HETEs cholesteryl esters 17.747636586863
9000395 Oxy-16 Exclusive 596-94-1 >95% ✓ 2010-09-15 36.048853591160 oxy-16 20(R),22(R)-dihydroxy Cholesterol oxysterols sterols hedgehogs bone formations cardiovascular diseases inflammation macrophage antagonist oxy16 16 26649-05-8 26622-99-1 4005-81-6 15234-55-6 Hhs signalling signaling oxy 16 Besins-Iscovesco Brand of Androstanolone Besins Iscovesco Brand of Androstanolone Berenguer Infale Brand of Androstanolone beta-Hydroxy-5 beta-Androstan-3-One, 17 17 beta-Hydroxy-5 beta-Androstan-3-One 17 beta Hydroxy 5 beta Androstan 3 One 17beta-Hydroxy-5alpha-Androstan-3-One 17beta Hydroxy 5alpha Androstan 3 One Cuxson Brand of Androstanolone 5-alpha Dihydrotestosterone 5 alpha-Dihydrotestosterone 5 alpha Dihydrotestosterone 5 beta-Dihydrotestosterone 5 beta Dihydrotestosterone Dihydroepitestosterone Steroids, Catatoxic Dihydrotestosterone Catatoxic Steroids Diflucortolone Androstanolone Pregnatrienes Norpregnenes Azasteroids 5-alpha-DHT 5 alpha DHT Ro 10-7614 Ro 10 7614 Stanolone Ro 107614 Andractim Anaprotin Steroids Cholenes Gelovit 36.048853591160
70515 Ozagrel 82571-53-7 >98% 0.656629834254 ozagrel OKY-046 thromboxanes synthases inhibitors inhibits imidizoles TXAs antihypertensive inhibition atherosclerosis 0.656629834254
10011301 p38 MAPK Monoclonal Antibody (Clone 9F12) - 2008-05-22 1.869005524861 p38-mapk-monoclonal-antibody-clone-9f12 p38 Mitogen-activated Protein Kinase; p38 MAPKα serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC 1.869005524861
10010374 p38 MAPK (Phospho-Thr180/Tyr182) Cell-Based Phosphorylation/Translocation Assay Kit - 2007-09-17 2.067087608524 p38-mapk-phospho-thr180-tyr182-cell-based-phosphorylation-translocation-assay-kit phosphorylation kits assays enzymes diseases asthma autoimmunity stress response nervous system fluorescence fluorescent fluorometric 2.067087608524
760901 PAF Acetylhydrolase Assay Kit - 87.800718232044 paf-acetylhydrolase-assay-kit PAF-AH; Lp-PLA2 PAF-AH colorimetric phospholipids atherosclerosis cytosolic extracellular platelet-activating factors PAFs enzymes analysistools:cytpafah analysistools:expafah assays paf elisa kit 87.800718232044
160603 PAF Acetylhydrolase (human) Polyclonal Antibody - 12.894806629834 paf-acetylhydrolase-human-polyclonal-antibody Platelet-activating Factor Receptor Acetylhydrolase; PAF-AH; Lp-PLA2 atherosclerosis platelet-activating factors Western blots asthma inflammation preeclampsia antisera PAFs WB antibodies antiserum blotting immunoblotting 12.894806629834
10010081 PAF Acetylhydrolase (human) Western Ready Control - 2007-05-30 5.758508287292 paf-acetylhydrolase-human-western-ready-control PAF-AH; Lp-PLA2; Platelet-activating Factor Acetylhydrolase; Lipoprotein PLA2 western blotting WB atherosclerosis factors asthma inflammation PAFs 5.758508287292
10004380 PAF Acetylhydrolase Inhibitor Screening Assay Kit - 2004-03-29 53.565641497851 paf-acetylhydrolase-inhibitor-screening-assay-kit PAF-AH Inhibitor Screening Assay Kit; Lp-PLA2 Inhibitor Screening Assay Kit platelet-activating factors hypotension inflammations allergys PAFAH atherosclerosis heart diseases measures kits inhibitors PAFs assays paf elisa kit 53.565641497851
60900 PAF C-16 74389-68-7 >98% 19.951337016574 paf-c-16 Platelet-activating Factor C-16 PAFs platelet-activating factors atherosclerosis 19.951337016574
360900 PAF C-16-d4 - ≥99% deuterated product 22.865635359116 paf-c-16-d4 Platelet-activating Factor C-16-d4 PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis 22.865635359116
60910 PAF C-18 74389-69-8 >97% 11.656850828729 paf-c-18 PAFs platelet-activating factors atherosclerosis 11.656850828729
10010229 PAF C-18 -d4 Exclusive - ≥99% deuterated product ✓ 2010-11-03 11.223171270718 paf-c-18-d4 PAFs platelet-activating factors atherosclerosis deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 11.223171270718
160600 PAF Receptor (human) Monoclonal Antibody (11A4, Clone 21) - 14.686232044199 paf-receptor-human-monoclonal-antibody-11a4-clone-21 Platelet-activating Factor Receptor platelet-activating factors antibodies PAFs ICC immunocytochemistry antisera antiserum flow cytometry FACS receptors atherosclerosis PAFR FC 14.686232044199
160602 PAF Receptor (human) Polyclonal Antibody - 14.014165745856 paf-receptor-human-polyclonal-antibody Platelet-activating Factor Receptor platelet-activating factors antisera PAFs antiserum antibodies flow cytometry facs immunocytochemistry icc western blots blotting wb atherosclerosis PAFR FC immunoblotting 14.014165745856
10009871 Palmitoleic Acid 373-49-9 ≥99% 2008-08-25 9.105432780847 palmitoleic-acid Palmitoleate; cis-Palmitoleic Acid; 9-cis-Hexadecenoic Acid; n-7 Palmitoleate monounsaturated fatty acids LDL HDL cholesterol diet 9.105432780847
62924 PAz-PC 117746-89-1 >98% 4.580678768744 paz-pc Azelaoyl PC; 1-Palmitoyl-2-Azelaoyl PC PPAR.gamma. PPARgamma receptors thiazolidinediones binding sites atherosclerosis 4.580678768744
10007185 PCSK9 (human) Polyclonal Antibody - 2005-11-30 20.565274927650 pcsk9-human-polyclonal-antibody Proprotein Convertase Subtilisin Kexin 9; NARC-1 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases family lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols livers kidneys lungs spleens jejunums ileums colons muscles golgi tissues atherosclerosis immunoblotting 20.565274927650
10218 PCSK9 Monoclonal Antibody (Clone 15A6) - 2008-10-29 13.274198895027 pcsk9-monoclonal-antibody-clone-15a6 Proprotein Convertase Subtilisin Kexin 9; NARC-1 antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots 13.274198895027
10008811 PCSK9 (mouse) Polyclonal Antibody - 2007-01-22 16.655783658040 pcsk9-mouse-polyclonal-antibody Proprotein Convertase Subtilisin Kexin 9; NARC-1 immunoblot neural apoptosis regulated convertase 1 atherosclerosis proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols atherosclerosis PCSK-9 immunoblotting 16.655783658040
10240 PCSK9 Polyclonal Antibody - 2009-07-21 6.439410681399 pcsk9-polyclonal-antibody NARC-1; Proprotein Convertase Subtilisin Kexin 9 PCSK-9 PCSK 9 western blots ICC WB immunocytochemistry protease LDLs lipoproteins low-density low density cholesterol immunoblotting blotting 6.439410681399
10009567 PCSK9 Western Ready Control - 2007-01-31 8.248634569850 pcsk9-western-ready-control Proprotein Convertase Subtilisin Kexin 9; NARC-1 PSEC0052 subtilisin serine proteases LDLs low density lipoproteins cholesterol receptors golgi atherosclerosis 8.248634569850
10010518 PD 146176 4079-26-9 ≥98% 2009-02-25 31.652648041431 pd-146176 NSC 168807 atherosclerosis 15-LOs 15-lipoxygenases oxidant injury injuries apoptosis amyloid β proteins inhibitors inhibits inhibitions Alzheimers disease oxidative stress pd146176 31.652648041431
101707 PGC-1 Polyclonal Antibody - 2005-10-12 29.541506780512 pgc-1-polyclonal-antibody PPARγ Coactivator 1; Peroxisome Proliferator-activated Receptor γ Coactivator 1 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity endocrinology immunoblotting 29.541506780512
10044 PGPC 89947-79-5 >98% 2004-01-21 7.017366482504 pgpc PPAR.gamma. PPARgamma oxidized LDL lipds agonists atherosclerosis nuclear receptors thiazolidinediones sites peroxisome low-density lipoproteins e-selectin vcam1 vcam-1 binding 7.017366482504
10009926 Phosphatidylcholine Assay Kit - 2007-07-10 57.364999999999 phosphatidylcholine-assay-kit PC Assay Kit assays kits ceramides phospholipids atherosclerosis phosphorylcholines phosphocholines glycerol cells membranes fatty acids lipoproteins homeostasis sphingomyelin SM atherosclerosis atherosclerotic lesions serums plasmas quantifying quantification colorimetric PC PLD phospholipases 57.364999999999
19020 Pinane Thromboxane A2 71111-01-8 >98% 10.694309392265 pinane-thromboxane-a2 PTA2; Pinane TXA2 Thromboxanes analogs TXA2 antagonists TP receptors atherosclerosis 10.694309392265
10031 POV-PC 121324-31-0 >98% 12.969235727440 pov-pc 2-(5-oxovaleryl) Phosphatidylcholine oxidative injury lipids stress oxLDL oxidized low-density lipoproteins CD36 CD-36 PMNLs polymorphonuclear leukocytes atherosclerosis phosphatidylcholines scavengers receptors LPS-binding affinity potent structural determinant inhibits inhibition inhibitors lipopolysaccaride atherosclerosis 12.969235727440
10009088 PPARα LBD (human recombinant) - ≥90% 2006-09-13 28.164267955801 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor α Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting 28.164267955801
101710 PPARα Polyclonal Antibody - 24.229699201964 ppar-polyclonal-antibody Peroxisome Proliferator-activated Receptor α peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a antibodies ligands ligand-activated activates activated lipids homeostasis fatty acids FAAH NSAIDs prostaglandins PGs luekotrienes LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic drugs transcriptionally regulates regulated regulation genes enzymes proteins metabolism oxidation acyl-CoA CoA oxidase enol-CoA hydratase chains dehydrogenase transports cytochrome P450 4A isoenzymes northern blots blotting immunoblotting liver skeletal muscle hearts kidney amino acids Atherosclerosis 24.229699201964
10006915 PPARα Transcription Factor Assay Kit - 2005-08-25 32.840877478063 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor α Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 32.840877478063
10008878 PPARα, δ, γ Complete Transcription Factor Assay Kit - 2006-08-22 50.811397000789 ppar-complete-transcription-factor-assay-kit PPARα PPARδ PPARγ PPAR-α PPAR-δ PPAR-γ PPAR α PPAR δ PPAR γ PPARalpha PPARdelta PPARgamma PPAR-alpha PPAR-delta PPAR-gamma delta alpha gamma PPAR.alpha. PPAR.delta. PPAR.gamma. PPAR-.alpha. PPAR-.delta. PPAR-.gamma. .alpha. .gamma. .delta.peroxisomes proliferator-activated proliferator activated receptors PPARs completes TF factors assay kits atherosclerosis endocrinology metaboli syndrome metabolism nuclear obese obesity PPAR non-radioacitve radioactive DNA detecting whole cells lysates 96-wells 96 wells immunosorbent ELISA enzyme-links enzyme-linked enzyme links linked electrophoretic mobility shifts EMSA double stranded dsDNA HRP colorimetric 50.811397000789
61700 PPARγ FL (human recombinant from E. coli) - >90% by SDS-PAGE 2007-01-10 21.181080417433 ppar-fl-human-recombinant-from-e-coli Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone 21.181080417433
10009987 PPARγ FL (human recombinant from Sf21 cells) - ≥80% by SDS-PAGE 2007-06-15 61.004459352801 ppar-fl-human-recombinant-from-sf21-cells Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology 61.004459352801
10007685 PPARγ FP-Based Ligand Screening Assay Kit - Green - 2009-07-16 42.257910597690 ppar-fp-based-ligand-screening-assay-kit-green Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists 42.257910597690
10007941 PPARγ LBD (human recombinant) - ≥90% 2006-03-16 19.116820135051 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent 19.116820135051
71000 PPARγ Ligand Pack - >98% 64.870607734806 ppar-ligand-pack Peroxisome Proliferator-activated Receptor γ Pack ligands ppar.gamma. ppargamma receptors antagonists antidiabetic diabetes peroxisome nuclear receptors proliferator-activated 15-deoxy-delta12,14-PGJ2 rosiglitazone ciglitazone troglitazone MCC-555 MCC555 thiazolidinediones TZD GW9662 GW-9662 15-deoxy-d12,14-PGJ2 15-deoxy-.DELTA.12,14-PGJ2 nuclear receptors pioglitazone (potassium salt) 71740 18570 71742 70735 71745 10004272 GW 501516 GW501516 atherosclerosis packs 64.870607734806
101700 PPARγ Polyclonal Antibody - 13.619415943173 ppar-polyclonal-antibody Peroxisome Proliferator-activated Receptor γ peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g antibodies ligands ligand-activated activated activates activated transcription factors lipids homeostasis regulator regulates adipogenesis mRNA tissues large small intestines kidneys livers genes PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ1 PPAR-γ-1 PPAR-gamma1 PPAR-gamma-1 PPAR-.gamma.1 PPAR-.gamma.-1 PPAR-g-1 PPAR-g1 PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ2 PPAR-γ-2 PPAR-gamma2 PPAR-gamma-2 PPAR-.gamma.2 PPAR-.gamma.-2 PPAR-g-2 PPAR-g2 amino acids western blots immunoblotting blotting WB atherosclerosis endocrinology metabolism nuclear receptors 13.619415943173
10006855 PPARγ Transcription Factor Assay Kit - 2005-08-25 58.305307550644 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor γ Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 58.305307550644
10007451 PPARδ (human recombinant) - ≥95% 2005-07-29 11.494211172498 ppar-human-recombinant PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; NUC1; FAAR peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 11.494211172498
101720 PPARδ Polyclonal Antibody - 2004-11-05 18.859161225514 ppar-polyclonal-antibody Nuclear Hormone Receptor 1; NUC1; FAAR; PPARβ PPAR.delta. PPAR.beta. PPARbeta peroxisome proliferator-activated receptors PPARdelta antibodies antisera nuclear receptors antiserum western blots blotting WB ICC immunocytochemistry IHC immunohistochemistry atherosclerosis endocrinology immunoblotting antibodies 18.859161225514
10006914 PPARδ Transcription Factor Assay Kit - 2005-08-23 35.103345994475 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor δ Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 35.103345994475
10009568 PPARδ Western Ready Control - 2007-02-02 5.079270718232 ppar-western-ready-control NUC1; PPARβ; FAAR; Nuclear Hormone Receptor 1; Peroxisome Proliferative Activated Receptor δ peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity 5.079270718232
10010343 Pravastatin (sodium salt) 81131-70-6 >98% 2008-03-04 12.052805840568 pravastatin-sodium-salt atherosclerosis HMGCoA HMG-CoA reductase LDL-c HDL-c statins cholesterol heart diseases CVD pravachol lipostat inhibitors inhibits inhibitions cardiovascular 12.052805840568
10011724 Propenyl-L-NIO (hydrochloride) Exclusive - >90% ✓ 2008-08-19 5.421243093922 propenyl-l-nio-hydrochloride ENIPO nitric oxide synthase NOS iNOS selective inhibitors inhibits inhibition 5.421243093922
10008841 Propylpyrazole Triol 263717-53-9 >98% 2007-01-25 78.562078729281 propylpyrazole-triol PPT 17b-estrogen 17beta-estrogen 17.beta.-estrogen receptors ERalpha ER.alpha. ERbeta ER.beta. agonist ischemia DPN diarylpropinitrile in vivo infarct endocrinology 78.562078729281
13010 Prostaglandin E1 745-65-3 >98% 56.894554941681 prostaglandin-e1 Alprostadil; PGE1 PGE1 vasodilation atherosclerosis erectile dysfunction prostaglandins pharma:1 56.894554941681
313010 Prostaglandin E1-d4 - ≥99% deuterated product 24.456611418048 prostaglandin-e1-d4 Alprostadil-d4; PGE1-d4 GC/MS deuterium isotopes PGE1-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry atherosclerosis 24.456611418048
10007939 Prostaglandin E Synthase-1 (microsomal) (human recombinant) - 16,000 x g supernatant 2009-03-15 25.421565377532 prostaglandin-e-synthase-1-microsomal-human-recombinant Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 25.421565377532
10009734 Prostaglandin E Synthase-1 (microsomal) Western Ready Control - 2007-05-01 8.713128453038 prostaglandin-e-synthase-1-microsomal-western-ready-control PIG12; mPGE Synthase-1; MGST-L1; Prostaglandin H/E Isomerase; Memebrane-Associated PGES-1 western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 8.713128453038
17020 Prostaglandin H2 42935-17-1 >95% 141.098321823205 prostaglandin-h2 PGH2 PGH2 endoperoxides cyclooxygenase vasoconstrictors prostaglandins PGHS2 syntahses cox-2 cox2 PGHS-2 atherosclerosis 141.098321823205
18220 Prostaglandin I2 (sodium salt) 61849-14-7 >99% 104.684802370443 prostaglandin-i2-sodium-salt Prostacyclin; Epoprostenol; PGI2 PGI2 metabolites prostaglandins salts Na+ COX cyclooxygenases atherosclerosis 104.684802370443
18300 Prostaglandin I3 (sodium salt) Exclusive 68324-96-9 >99% ✓ 101.291160220994 prostaglandin-i3-sodium-salt PGI3 (Na salt) w-3 omega-3 PGI3 prostaglandins atherosclerosis .omega.-3 salts Na+ 101.291160220994
160630 Prostaglandin I Synthase Monoclonal Antibody (Clone isn-1) - Protein-A purified 5.170662983425 prostaglandin-i-synthase-monoclonal-antibody-clone-isn-1 Prostacyclin Synthase; PGIS; PGI Synthase synthases endothelium PGI2 prostaglandins antibodies antisera antiserum Bovine PGI synthase atherosclerosis neurochemistry IP immunoprecipitation IHC immunohistochemistry 5.170662983425
100023 Prostaglandin I Synthase (murine) Polyclonal Antibody - 2004-06-30 10.323301104972 prostaglandin-i-synthase-murine-polyclonal-antibody PGIS; Prostacyclin Synthase; PGI Synthase antibodies antisera antiserum western blots blotting wb IHC immunohistochemistry prostaglandins prostacyclins synthases receptors atherosclerosis immunoblotting 10.323301104972
160640 Prostaglandin I Synthase Polyclonal Antibody - 8.795432780847 prostaglandin-i-synthase-polyclonal-antibody Prostacyclin Synthase; PGIS; PGI Synthase PGIS prostacyclin synthases endothelium Western blots PGI2 prostaglandins blotting antisera antiserum immunoprecipitation IP antibodies atherosclerosis WB immunoblotting 8.795432780847
13294 Pyrrophenone 341973-06-6 ≥90% 2010-04-07 51.947504688529 pyrrophenone phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory Pyrrolidines 51.947504688529
10006217 Renin (human recombinant) - >99% by SDS-PAGE 2004-12-13 86.178273480663 renin-human-recombinant enzymes aspartyl proteases angiotensins II glycoproteins angiotensinogen salt balance hypertension angiotensinogens kidney renal preprorenin atherosclerosis endocrinology 86.178273480663
10006270 Renin Inhibitor Screening Assay Kit - 2005-05-04 71.973945160630 renin-inhibitor-screening-assay-kit Protease measurement assays aspartyl renal juxtaglomerular cells sodium depletion blood volume pressure .beta.-adrenergic stimulation angiotensinogens angiotensins I II converting ACE monomeric zinc metalloenzymes vascular endothelium messengers RAS vasoconstrictor peripheral hypertension receptors blockers fluorescence fluorescent fluorometric atherosclerosis endocrinology 71.973945160630
10012554 Resolvin D1 Exclusive 872993-05-0 ≥95% ✓ 2008-06-06 256.881973164956 resolvin-d1 RvD1; 17(S)-Resolvin D1 EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 256.881973164956
13900 Resveratrol-3-O-Sulfate 553662-69-4 ≥98% 2011-06-01 27.570370955011 resveratrol-3-o-sulfate polyphenol phytoalexin biochemicals physiological actions estrogenic antiplatelet anti-inflammatory piceid polydatin grape juices glucuronidated metabolites humans 27.570370955011
579070 Retinol Binding Protein 4 (human) Competitive EIA Kit - 2011-08-01 7.292605184870 retinol-binding-protein-4-human-competitive-eia-kit RBP4 binding proteins EIAs ELISAs enzymes immunoassays kits measures measurement insulin glucose homeostasis uptake skeletal muscles adipose tissues transporter 4 GLUT4 resistance vitamins A adipokines metabolic obesity syndromes cardiovascular diseases expression pro-inflammatory cytokines LDLs low-density lipoproteins cholesterols diet-induced obese hyperlipidemic hyperlipidemia dyslipidemia lipids metabolisms serums plasmas disorders 7.292605184870
10006415 Ro 48-8071 161582-11-2 >98% 2005-06-01 6.522028413575 ro-48-8071 monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis 6.522028413575
71740 Rosiglitazone 122320-73-4 >98% 142.434901341752 rosiglitazone BRL 49653 BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome atherosclerosis endocrinology 142.434901341752
10011343 Rosiglitazone-d5 Maleate - >99% deuterated product 2009-04-04 39.880375690608 rosiglitazone-d5-maleate SPI TZDs thiazolinedions PPARg PPAR.gamma. PPARgamma selective ligand insulin resistance anti-inflammatory 39.880375690608
71742 Rosiglitazone (potassium salt) 316371-84-3 >98% 99.240115519839 rosiglitazone-potassium-salt BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome salts thiazolidinediones atherosclerosis endocrinology 99.240115519839
10005260 Serine Palmitoyltransferase Polyclonal Antibody - 2004-12-02 27.718979742173 serine-palmitoyltransferase-polyclonal-antibody Serine-palmitoyl-CoA transferase, long chain base subunit 2; SPT antibodies antisera western blots blotting WB sphingolipids SPT2 immunohistochemistry immunohistochemical analysis IHC nuclear proteins nucleus immunoblotting 27.718979742173
10007681 Serum Retinol Binding Protein 4 Polyclonal Antibody Exclusive - ✓ 2007-08-03 3.454220994475 serum-retinol-binding-protein-4-polyclonal-antibody Plasma Retinol Binding Protein 4; pRBP; sRBP4 vitamin A wb western blotting type 2 diabetes lipocalin TTR transthyretin sRBP4 sRBP-4 proteins adipocytes signals signalling signaling insulin blots retinols serums RBP atherosclerosis endocrinology immunoblotting 3.454220994475
10010344 Simvastatin 79902-63-9 >98% 2008-02-27 21.422501973164 simvastatin MK 733 HMG-CoA reductase HMGCoA inhibits inhibitors inhibition LDL-c HDL-c statins cholesterol heart diseases CVD atherosclerosis zocor zetia exetimibe vytorin inegy TNF-.alpha. NF-.kappa.B apoptosis cancers cardiovascular NFkB atherosclerosis 21.422501973164
10010146 Soluble Epoxide Hydrolase Polyclonal Antibody - 2008-03-03 7.101390965226 soluble-epoxide-hydrolase-polyclonal-antibody Epoxide Hydrolase 2; EPHX2; sEH; Cytosolic Epoxide Hydrolase (CEH) metabolism hypertension inflammation EpETrEs EETs DiHETrEs DHET inhibitors inhibit inhibitions epoxyeicosatrienoic acids eicosatrienoic WB western blots blotting immunoblotting 7.101390965226
10006964 Sphingomyelinase Assay Kit - 2009-11-25 81.054033149171 sphingomyelinase-assay-kit SMase Assay Kit sphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNases I superfamily sphingomyelins phosphorylcholines ceramides cells cellular stress cations lysosomal acids secreted zinc-dependent membrane-bound magnesium-dependent neutral cytosolic magnesium-independent neutral alkalines mutations ASM genes Type A B Niemann-Pick diseases physiological pathophysiological lysosomal digestion neuronal vascular ceramide-mediated signal transduction cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessel walls atherogenesis intracellular trafficking metabolism assays kits measures measuring measurements acidic activity tissues homogenates lysates serum blood saliva urine coupled enzymatic reactions oxidases betaine h2o2 hydrogen peroxides horseradish peroxidases HRPs 10-acetyl-3,7-dihydroxyphenozazine ADHP fluorescent fluorescence 81.054033149171
700330 Sphingomyelinase Inhibitor Screening Assay Kit - 2010-02-09 37.411236516705 sphingomyelinase-inhibitor-screening-assay-kit SMase assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols 37.411236516705
19025 SQ 29,548 98672-91-4 ≥98% 87.390994475138 sq-29-548 thromboxanes TXA2 SQ-29548 SQ29548 analogs TP antagonists receptors atherosclerosis 87.390994475138
10010854 SREBP-1 Transcription Factor Assay Kit - 2008-06-24 39.851171731123 srebp-1-transcription-factor-assay-kit Sterol Regulatory Element-Binding Protein-1 Assay Kit tf atherosclerosis SREBPs sterols regulatory element binding proteins factors basic helix-loop-helix-leucine zipper family expression regulate synthesis regulation uptake cholesterol fatty acids triglycerides phospholipids adipocyte differentiation insulin-dependent genes SREBP-1a membrane-bound rough ER endoplasmic reticulum cleavage activating SREBP-Scap Golgi proteolytic two-step cleavage S1P S2P NH2 -terminal active domain nuclear localization signal importin nucleus upregulating genes fatty acids lipogenic enzymes acetyl CoA coenzymes A carboxylases synthases long chain elongases glucose glucokinases glycolysis diseases obesity diabetes mellitus insulin resistance non-alcoholic liver non-radioactive sensitve sensitivity detects detecting double stranded dsDNA extracts ELISA EMSA humans rats mouse mice murine SREBP1C SREBP 1c assays 39.851171731123
10009266 SREBP-2 Blocking Peptide - 2006-10-18 46.145828729281 srebp-2-blocking-peptide SREBF2; Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein-2 signaling signalling controls peptides proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry atherosclerosis 1a 1c basic helix-loop-helix bHLH transcription factors lipids homeostasis regulating genes cholesterols fatty acids metabolisms domains amino-terminals hydrophobic regions transmembranes segments carboxy regluates synthesis genes HMG-CoA reductases enzymes synthetics pathways tissues basal ER endoplasmic reticulum membranes glycosylateds nucleus cells livers brown fats testis HepG2 human fibroblasts 46.145828729281
10009239 SREBP-2 Cell-Based Translocation Assay Kit - 2007-04-17 33.059637814609 srebp-2-cell-based-translocation-assay-kit Sterol Regulatory Element-Binding Protein-2 Cell-Based Translocation Assay Kit sterol regulatory element binding proteins athersclerosis cholesterols fatty acids triglycerides phospholipids helix-loop-helix HLH transcription factors DyLight Pierce Biotechnology assays fluorescence fluorescent fluorometric cell-based assays cell based assay cba U18666A U 18666A U-18666A 33.059637814609
10007663 SREBP-2 Polyclonal Antibody - 2006-02-22 74.042265193369 srebp-2-polyclonal-antibody Sterol Regulatory Element-binding Transcription Factor 2; SREBF2; Sterol Regulatory Element-binding Protein-2 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry 1a 1c basic helix-loop-helix bHLH transcription factors lipids homeostasis regulating genes cholesterols fatty acids metabolisms domains amino-terminals hydrophobic regions transmembranes segments carboxy regluates synthesis genes HMG-CoA reductases enzymes synthetics pathways tissues basal ER endoplasmic reticulum membranes glycosylateds proteins nucleus cells livers brown fats testis HepG2 human fibroblasts endocrinology immunoblotting 74.042265193369
10007819 SREBP-2 Transcription Factor Assay Kit - 2006-09-20 40.857490216389 srebp-2-transcription-factor-assay-kit Sterol Regulatory Element-binding Protein-2 Assay Kit tf sterol regulatory element binding proteins cholesterol fatty acids triglycerides phospholipids atherosclerosis assays 40.857490216389
10009749 SREBP-2 Western Ready Control - 94 kDa (GST-tagged); 68 kDa (native) 2007-07-30 15.195226519336 srebp-2-western-ready-control Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein 2; SREBPF2 WB western blot helix loop bHLH fatty acids genes cholesterol regulatory HMG-CoA tissues E. coli SREBP2 SREBPF-2 transcription factors SREBP 2 atherosclerosis 15.195226519336
10011298 Stearic Acid 57-11-4 >98% 2008-10-10 16.679238581413 stearic-acid saturated fatty acids trans LDLs HDLs liporotein cholesterols dietary fats atherosclerosis 16.679238581413
10026 T0070907 313516-66-4 >98% 65.236381215470 t0070907 T-0070907 nuclear receptors antagonist PPARgamma PPAR.gamma. peroxisome proliferator-activated selective selectivity thiazolidinediones TZDs inhibits inhibition inhibitors atherosclerosis endocrinology 65.236381215470
71810 T0901317 293754-55-9 >98% 287.964116022099 t0901317 agonists to901317 TO-901317 T-0901317 t0-901317 receptors lipid nuclear hormone LXR.alpha.nuclear receptors LXR.beta. LXRalpha LXRbeta atherosclerosis 287.964116022099
10009911 Tangeritin 481-53-8 ≥98% 2008-12-16 11.958232044199 tangeritin Ponkanetin; NSC 618905; NSC 53909 flavone cancers tumors cholesterol atherosclerosis ERKs p38 MAPKs JNKs AKTs LDLs triacylglycerol estradiol MDR1 pregnane X receptors IL-1 IL1 IL 1 melanoma insulinoma 11.958232044199
10007349 TGX-221 663619-89-4 >98% 2006-02-21 22.249410681399 tgx-221 phosphatidylinositol-3-kinases PI3K catalyzes phosphorylation produces second messengers (3,4)-biphosphates -P2 (3,4,5)-P3 Class 1 p110.alpha. .beta. .delta. .gamma. p85 regulatory subunits cells permeable inhibitors inhibition inhibits ATP binding sites platelets defective thrombus formation antithrombotic therapy atherosclerosis 22.249410681399
19030 Thromboxane B2 54397-85-2 ≥99% 78.437133210558 thromboxane-b2 TXB2 thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis 78.437133210558
160720 Thromboxane B2 11-dehydrogenase Polyclonal Antiserum - 55.333204419889 thromboxane-b2-11-dehydrogenase-polyclonal-antiserum TXB2 11-dehydrogenase; ALDH1; Aldehyde Dehydrogenase; Retinal Aldehyde Dehydrogenase Western blots blotting erythrocyte thromboxanes TXB2 antisera antibodies antiserum WB atherosclerosis immunoblotting 55.333204419889
319030 Thromboxane B2-d4 - ≥99% deuterated product 27.777403314917 thromboxane-b2-d4 TXB2-d4 GC/MS deuterium isotopes internal standards GC-MS LC/MS LC-MS mass spectrometry atherosclerosis prostaglandins TXB2-d4 thromboxanes deuterated 27.777403314917
519031 Thromboxane B2 EIA Kit - 410.868976672805 thromboxane-b2-eia-kit solid plates TXB2 thromboxanes measures kits eias enzyme atherosclerosis immunoassays ELISAs assays 410.868976672805
10004023 Thromboxane B2 Express EIA Kit - Monoclonal - 2004-07-02 115.003458469093 thromboxane-b2-express-eia-kit-monoclonal TXB2 Express ELISA Kit - Monoclonal; TXB2 Express EIA Kit (Monoclonal) solid plates atherosclerosis thromboxanes measures kits eias enzyme immunoassays ELISAs intrarenal TXA2 synthesis fast same-day assays 115.003458469093
10007237 Thromboxane B2 Lipid Maps MS Standard 54397-85-2 ≥99% 2009-01-16 17.096325966851 thromboxane-b2-lipid-maps-ms-standard TXB2 thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis MS mass spectrometry standards 17.096325966851
19990 Thromboxane B3 71953-80-5 >98% 5.873425414364 thromboxane-b3 TXB3; Δ17-TXB2 .DELTA.17-TXB2 Thromboxanes TXB3 TXA3 omega-3 .omega.-3 w-3 d17-TXB2 DELTA17-TXB2 atherosclerosis 5.873425414364
160715 Thromboxane Synthase Polyclonal Antibody - 11.881104972375 thromboxane-synthase-polyclonal-antibody TX Synthase prostaglandins PGH2 platelet aggregation thromboxanes TXS Synthases western blots blotting WB antibodies antisera antiserum IHC immunohistochemistry atherosclerosis immunoblotting 11.881104972375
10005263 TOFA 54857-86-2 >98% 2004-07-28 57.209779005525 tofa RMI 14514; 5-(Tetradecyloxy)-2-Furoic Acid inhibits inhibitors inhibition ACC acetyl-CoA carboxylases fatty acid synthases synthesis FAS cerulenin apoptosis cancer C75 malonyl-CoA atherosclerosis endocrinology 57.209779005525
10004452 TP Receptor (human) Polyclonal Antibody - 2004-04-01 133.784629834254 tp-receptor-human-polyclonal-antibody TXA2 Receptor; Thromboxane A2 Receptor thromboxanes platelets metabolites TXA2 IHC immunohistochemistry antibodies antisera antiserum western blot blotting WB atherosclerosis immunoblotting ICC immunocytochemistry 133.784629834254
10012559 TP Receptor (human) Polyclonal FITC Antibody - 2008-07-25 76.754683855126 tp-receptor-human-polyclonal-fitc-antibody TXA2 Receptor; Thromboxane A2 Receptor antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IF immunofluorescence western blots blotting WB immunoblotting 76.754683855126
13044 Tranilast 53902-12-8 ≥98% 2008-08-29 83.935779005525 tranilast SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF 83.935779005525
70675 trans-Resveratrol 501-36-0 >98% 96.100285851549 trans-resveratrol (E)-Resveratrol selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins 3,5,4'-trihydroxystilbene 3,5,4'-trihydroxy-trans-stilbene 3,5,4'-THS 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene (E)-stilbenes AHR antagonists aryl hydrocarbon receptors 96.100285851549
13130 trans-Resveratrol-d4 - ≥99% deuterated product 2009-01-14 18.699378453038 trans-resveratrol-d4 (E)-Resveratrol-d4 selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins AHR antagonists aryl hydrocarbon receptors 18.699378453038
10162 Treprostinil 81846-19-7 >98% 2005-08-30 218.580605605111 treprostinil Remodulin® primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis Tyvasos Tyvaso® 218.580605605111
71750 Troglitazone 97322-87-7 >98% 165.226773480663 troglitazone ResulinTM antidiabetic thiazolidinediones PPAR.gamma. PPARgamma ligands selective peroxisome proliferator-activated receptors diabetes TZD Resulin nuclear receptors atherosclerosis endocrinology 165.226773480663
10009085 U-18666A 3039-71-2 >95% 2007-01-19 30.859149171270 u-18666a Niemann-Pick type C NPC apoptosis neuronal death Alzheimers AD neurodegeneratives diseases trafficking unesterified ER cells membranes cateracts epilepsy Free cholesterol loading NSC 70801 Endoplasmic reticulum atherosclerosis inhibits inhibitors inhibition endosomes lysomes oxidosqualene cyclases atherosclerosis 30.859149171270
16440 U-44069 56985-32-1 >98% 351.954530386740 u-44069 9,11-dideoxy-9α,11α-epoxymethano Prostaglandin F2α; 9,11-dideoxy-9α,11α-epoxymethano PGF2α; 9,11-epoxymethano Prostaglandin H2 endoperoxides methanoepoxy PGH2 thromboxanes analogs prostaglandins U44069 TP receptors agonists atherosclerosis 351.954530386740
16450 U-46619 56985-40-1 >98% 227.299350257979 u-46619 9,11-dideoxy-9α,11α-methanoepoxy Prostaglandin F2α; 9,11-dideoxy-9α,11α-methanoepoxy PGF2α endoperoxides PGH2 thromboxanes vasoconstriction analogs TP receptors agonists U46619 atherosclerosis 227.299350257979
16465 U-51605 64192-56-9 >98% 49.377216280602 u-51605 diazo endoperoxides inhibitors U51605 analogs PGH2 PGIs synthase prostaglandins inhibits thromboxanes atherosclerosis 49.377216280602
10003 Vasoactive Eicosanoid HPLC Mixture - >98% for each compound 22.412469613259 vasoactive-eicosanoid-hplc-mixture 11-dehydro-TXB2 2,3-dinor-6-keto-PGF1.alpha. 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-TXB2 12-HHTs 12(S)-HHTrEs 12-HHTrEs 12(S)HHTrEs thromboxanes prostaglandins eicosanoids mixtures 2,3-dinor-PGF1.alpha. 2,3-dinor-PGF1alpha chromatography atherosclerosis 22.412469613259
70730 Wy 14643 50892-23-4 >98% 112.485773480663 wy-14643 Pirinixic Acid activators peroxisome proliferator-activated receptors adipocytes obesity PPARalpha PPAR. nuclear receptors alpha. PPARgamma PPAR.gamma. PPARdelta PPAR.delta. atherosclerosis endocrinology wy14643 112.485773480663
18113 YM-53601 Exclusive 182959-33-7 ≥98% ✓ 2009-08-11 5.105911602209 ym-53601 squalene synthases inhibitors cholesterol triglycerides HMG-CoA reductase fibrates hyperlipidemia hypercholesterolemia lipid-lowering activities inhibitor inhibited 5.105911602209
71800 (Z)-Guggulsterone 39025-23-5 ≥98% 2009-12-01 0.489963167587 -z-guggulsterone anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt 0.489963167587
90210 α-Linolenic Acid 463-40-1 >98% 13.113828729281 -linolenic-acid ALA fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 essential leafy green vegetables alpha-linolenic .alpha.-linolenic 13.113828729281
9000433 α-Linolenic Acid-d14 - ≥99% deuterated product 2010-09-13 7.645997544506 -linolenic-acid-d14 ALA-d14 fatty acids PUFAs omega-3 ω-3 polyunsaturated essential leafy green vegetables deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards alpha-linolenic α-linolenic signaling ALAS α-linolenic 7.645997544506
16460 Δ17-U-46619 - >98% 74.246914866901 -17-u-46619 d17-u-46619 delta17-u-46619 .delta.17-u-46619 thromboxanes TXA3 analogs agonists d17-u46619 delta17-u46619 .delta.17-u46619 atherosclerosis 74.246914866901
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?